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ABSTRACT 
 
Small lytic phages compelled by the same evolutionary pressures as large 
dsDNA phages have evolved mechanisms to lyse their hosts efficiently and at optimal 
times to ensure maximum fecundity. The ssDNA Microviridae and ssRNA Leviviridae, 
with extremely small genomes (<6kb), effect lysis with a single gene. The most studied 
single-gene lysis systems (SGL) are gene E of the canonical microvirus X174 and 
genes A2 and L of the paradigm ssRNA phages Q and MS2, respectively. All three lysis 
proteins lack muralytic activity, and two, A2 and E, have been shown to function as 
“protein antibiotics” by acting as noncompetitive inhibitors of conserved peptidoglycan 
(PG) biosynthesis enzymes, MurA and MraY, respectively.  The third, L of MS2, does 
not inhibit PG biosynthesis but instead is hypothesized to trigger host autolytic response 
through an unknown mechanism. 
The work described in this dissertation identifies a chaperone involved in MS2 
L-mediated lysis, the minimal lytic domain of L, and a new paradigm in SGL that 
resolves a long-standing debate in peptidoglycan biosynthesis. Using a genetic approach, 
dnaJ was shown to be required for L-mediated lysis. DnaJ was shown to form a complex 
with L and this interaction is abrogated in the absence of the highly basic N-terminal half of 
L. Mutational analysis of L has revealed that most critical residues are clustered around a 
highly-conserved LS motif. To determine if SGL evolved at different genomic locations 
target other steps in PG biosynthesis we studied of the lysis mechanism of LysM from an 
E. coli phage M. Both genetic and biochemical analysis have demonstrated that LysM 
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targets MurJ, the proposed Lipid II flippase candidate, and blocks Lipid II flipping to 
effect host lysis. Thus, the results presented in this dissertation provide the most 
convincing evidence in favor of MurJ being the Lipid II flippase. Additionally, the 
results highlight the plasticity of ssRNA phages to evolve inhibitors against proteins 
involved in PG biosynthesis and maintenance.  
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Viruses of bacteria or bacteriophages are natural biocontrol agents that play a 
critical role in maintaining and driving bacterial diversity in every environmental niche 
(1). In fact, it is estimated that phage outnumber bacteria by ~10-fold, with an estimated 
1031 phages on the planet (2). This astounding number is a testament of their 
reproductive and evolutionary success. As obligate intracellular parasites of bacteria, 
phages have evolved a wide variety of highly efficient mechanisms to both enter and exit 
their host (3, 4).  
As the most abundant and well-studied group of phages, the tailed phages of 
Caudovirales, begin their infection cycle by adsorbing to the host cell. Adsorption of a 
phage on the host entails a “ligand-receptor” binding between the phage tail fibers (or 
attachment proteins) and the surface features on the host (5, 6). Upon recognition of the 
host receptor, the phage tail machinery springs into action and locally breaches the host 
cell envelope to deliver its genetic material and accessory proteins (3). This local breach 
in the envelope is thought to be immediately repaired or plugged by host and/or phage 
proteins, albeit molecular evidence for either process is lacking (7). The molecules and 
mechanisms of phage DNA entry remain an understudied aspect of phage biology. 
Nevertheless, based on a handful of well-studied phages, it is evident that phages have 
evolved a variety of molecules to successfully breach the host cell envelope at the time 
of infection.                         
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 The time after DNA ejection and the appearance of the first virus-like particles 
in the host is referred to as the latent period. During this time the host biosynthetic 
machinery is hijacked by the phage to synthesize viral DNA and proteins. Four 
independent late-stage processes viz., head assembly, tail assembly, DNA packaging, 
and lysis, are initiated during the latent period. The phage particles begin to assemble 
and continue to accumulate intracellularly until a genetically programmed lysis event. 
Lysis of the host concludes the latent period of phage infection. 
Lysis of the host results in release of progeny virions into the environment and 
the precise timing of this event has profound impact on the fecundity of the phage (8, 9). 
The genetic ablation of the lysis event has no effect on the rate of intracellular 
accumulation of phage particles. In fact for phage mutants with inactivated lysis genes, a 
10-fold increase in progeny virions per cell has been reported (10, 11). Yet normally 
lysis occurs at an optimal lysis time that provides the phage an overall fitness advantage. 
To effect lysis, a phage must compromise the host envelope, which in Gram-negative 
bacteria is comprised of the asymmetric outer membrane (OM), a thin layer of highly 
cross-linked peptidoglycan (PG), and the cytoplasmic or inner membrane (IM). To date 
there are two broad strategies to effect lysis, one involving an intricate, precisely timed, 
step-by-step breakdown of each barrier of the host envelope (12). This is achieved by 
proteins that have evolved to specifically disrupt each layer of the host envelope. This 
system is reliant on a precise molecular clock (holins) that disrupts the cytoplasmic 
membrane at an allele-specific time. Once the cytoplasmic membrane is compromised, 
the peptidoglycan is degraded by endolysins and the OM is disrupted by spanins (13). 
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This system is employed by large dsDNA phages that have ample genomic space to 
evolve a variety of lysis proteins and their regulators (4) (Figure 1.1). The other strategy 
of lysis is employed by small lytic phages with genomes less than 6kb. Limited by their 
small genome size and compelled by the evolutionary pressure to lyse at an optimal 
time, they too have evolved genes to effect lysis. In contrast to dsDNA phages, these 
small viruses encode a single gene to overcome all the barriers of the host envelope (14).  
The work described below is concerned with “single gene lysis” of host cells by small 
lytic phages, the evolution of their lysis genes, and the diversity of the host targets and 
lysis mechanisms.   
  
 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 The various lysis proteins and lysis regulators of Caudovirales. 
The cytoplasmic membrane, the cell wall (PG), and the OM barriers of the Gram-
negative cell envelope are shown as vertical columns. The six different classes of lysis 
proteins (yellow) that compromise different layers of the cell envelope are shown in their 
respective columns. The positive and negative regulators of the lysis proteins are 
highlighted in green and red respectively. The lysis proteins that are capable of sensing 
environmental cues are indicated by blue lightning bolt.  
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Phages with small genome size 
Bacteriophages with genome sizes <6 kb represent some of the simplest viruses 
in the biosphere. The genetic material of these viruses is composed of either single 
stranded or double stranded nucleic acids. Based on the type of nucleic acids, these 
viruses can be broadly classified into RNA and DNA phages. RNA genomes can be 
either ssRNA or dsRNA, while DNA viruses with small genomes are mostly ssDNA 
(15). From a historical standpoint, these viruses were initially isolated with the purpose 
of using them as model organisms for studying some basic biological processes such as 
DNA and RNA replication, transcription, translation, and macromolecular assembly (16, 
17).  
ssDNA phages 
  Based on the symmetry of viral structure, ssDNA phages are classified in two 
broad groups, as linear filamentous ssDNA phages and “cubic” ssDNA phages. 
Filamentous phages (M13, and f1) composed of circular ssDNA encased in long flexible 
tube were isolated as a group of male-specific phages. Instead of lysing their hosts, 
filamentous phages extrude through the host membrane at a steady rate. Since 
filamentous phages are not lytic, they will not be covered in this dissertation. On the 
other hand, small icosahedral bacteriophages with closed circular (+) sense ssDNA of 
the family Microviridae represent the most abundant and ubiquitous small genome 
phages (18, 19). 
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ssDNA viruses: the Microviridae 
Microviridae is a family of small icosahedral phages with covalently closed 
circular (+) sense ssDNA genomes. They are ubiquitous, having even been found for 
intracellular bacteria such as Chlamydia (20, 21). The prototypic member of 
Microviridae is the famous E. coli phage X174; its unique features/properties have 
enabled some of the most important achievements in molecular biology. The DNA 
genome of X174 was the first DNA whole genome sequencing project to be completed 
(22, 23). Because of its simplicity and availability of complete genome sequence, it 
served as model system for studying processes such as DNA replication, transcription, 
gene expression, and viral assembly (17). Its DNA was also the first to undergo site-
directed mutagenesis and the first fully synthetic genome (24, 25). 
The 5386-nucleotide genome of X174 encodes 11 genes, of which 9 are 
essential (26). There are four genes that are either completely or partly embedded in 
other genes, some as alternate starts in a single frame and others as alternate reading 
frames (Figure 1.2). The gene A* is embedded within the same reading frame of gene A. 
Genes B and E are completely embedded in alternate reading frames of genes A and D 
respectively, while gene K overlaps both gene A and gene C (17). 
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Figure 1.2 Genome organization and capsid assembly of X174 
(A) Genome map of X174. (B) X174 virion assembly pathway. This figure was 
adapted from (27). 
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  The infection of X174 begins with the recognition of terminal glucose and 
galactose residues in the LPS core of E. coli C (28). The common laboratory strain E. 
coli K-12 is naturally resistant to X174 but it can be sensitized by altering the structure 
of LPS core (29). The glucose-binding site is present in the coat protein, made up of six 
conserved residues make up the binding site (30, 31). The binding of virions to the LPS 
core is reversible and dependent on the presence of Ca+2 ions, which stabilizes the side-
chains of the binding site residues (32). The binding of glucose is a reversible reaction, 
which presumably allows the virus to roll along the surface of the host until proper 
recognition of the secondary receptor (33). The binding to secondary receptor is an 
irreversible reaction and results in the ejection of DNA from the capsid (34). The DNA 
ejection requires the pilot protein H, which is present in 10-12 copies per virion, at one 
of the 5-fold vertices (17). It was speculated that an oligomer of H-protein forms a DNA 
channel through the cell wall (35). Indeed, recent crystallographic and cryo-EM studies 
have shown that H-protein form a 22 Å conduit (tail-like structure) that traverses the 
entire length of the periplasmic space and contacts the IM (36). The central pore of the 
tail-like structure is wide enough to accommodate two strands of ssDNA. Upon 
penetration into the host cell, genome replication occurs and the process can be divided 
into three stages. In the first stage, the (+) sense ssDNA is converted into a circular 
dsDNA species known as the “replicative form I DNA” (RF I DNA) (37). During second 
stage, (+) sense DNA is amplified through rolling circle replication of RF I DNA (38). In 
the final stage, the circular ssDNA genome is synthesized and packaged into the 
procapsids. For viral genes to be transcribed and translated the negative strand synthesis 
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must first occur to serve as template for transcription. Unlike large ds DNA phages, 
temporal regulation of expression of genes is completely under the control of cis-acting 
elements like promoters and terminators, and Shine-Dalgarno (SD) sequences and also 
on mRNA structure and stability. The promoters for genes are found upstream of genes 
A, B, and D, and terminator sequences after genes J, F, G, and H. The terminators in 
X174 are not efficient and allow leak-through transcription and translation (17). The 
lysis gene E is on all the transcripts, unlike in dsDNA phages where lysis genes are late 
genes (39, 40). 
The viral morphogenesis begins with the formation of two types of pentamers, 
one composed of the spike protein G and the other made up of coat protein F (Figure 
1.2) (27). The binding of internal scaffolding protein B to F pentamers (F5) facilitates the 
interaction of G protein pentamers (G5) and tetramers of the external scaffolding protein 
D to F5 and B complex. Incorporation of H protein into the spike complex completes the 
formation of the procapsid. The packaging of DNA along with the highly basic J protein 
initiates the maturation process. During this, the B protein is extruded and the external 
scaffold protein D is released to form a mature virion (27).  
X174 has a burst size of ~200 virions per cell with cell lysis at ~20 after 
infection. The lysis protein E, a 91 aa protein with an essential N-terminal 
transmembrane domain (TMD) is responsible for effecting host lysis (41, 42). E-
mediated lysis is described in detail in later sections of Chapter I. 
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dsRNA phages 
The phage 6, founding member of the family Cystoviridae, was isolated in 1973 
from bean plants as a type IV pili-specific, lipid-containing, and segmented dsRNA 
phage (43, 44).  Its genome contains three dsRNA segments designated as L, M, and S 
with sizes 6.5 kbp, 4 kbp, and 3 kbp respectively (Figure 1.3). The largest of the dsRNA 
segments, L, encodes the major structural protein (P1) of the inner core, RNA-dependent 
RNA polymerase (P2), packaging NTPase (P4), and accessory protein P7 (45). Together 
these four components form the dodecahedron inner core, which is encased in a shell of 
P8, encoded by gene 8 on segment S. The P8 shell is in turn surrounded by lipid-
containing membrane that harbors proteins for host recognition and accessory proteins 
(Figure 1.3) (46). The assembly of particles begins with the formation of the inner core.  
The nucleation for inner core assembly begins with the interaction between tetramers of 
P1 and hexamers of P4 (47). At this stage, empty procapsids appear to be invaginated or 
deflated with 5-fold vertices sloping towards the center of the capsid (48).  
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Figure 1.3 Genome organization and structure of cystovirus 
(A) Genome organization of segmented dsRNA phage phi6.  (B) A cartoon rendition of 
cystovirus structure. dsRNA (red circle) is enclosed in a core of P1, P2, P4 and P7. The 
core structure is encapsulated within a shell of P8, which is in turn covered by the lipid-
containing membrane. Attachment protein P6 and P3 are in the membrane along with P9 
and P10. This figure was adapted from (46) 
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The (+) strands of S, M, and L segments are packaged into the procapsid 
sequentially in 5’ to 3’ direction (49). It has been proposed that the surface of empty 
procapsid specifically binds to (+) strand of the S segment and initiates packaging 
through the hexameric NTPase, P4, present at twelve 5-fold vertices (50). Hydrolysis of 
NTPs by P4 drives the packaging of RNA into the capsids. Packaging of (+) strand of 
the S segment induces conformational change that exposes binding site for M segment. 
After M segment is packaged another conformational change facilitates the packaging of 
L segment. Packaging of L segment activates RNA-dependent RNA polymerase P2 to 
synthesize (-) strands to double the RNA content within the capsid. At this stage, the 
capsid becomes inflated and the hexameric P4 protrudes outside as knobs at every 
vertex, this structure constitutes the viral core.  The negative strand of dsRNA serves as 
a template to transcribe (+) sense RNA that is extruded out of the capsid to be translated 
in the host cytoplasm. The same (+) sense RNA molecules are packaged into progeny 
virions (46). The viral core then serves as a template for the assembly of nucleocapsid 
protein P8. The nucleocapsid encapsulated virions can interact with host cytoplasmic 
membrane and cause infection in spheroplasts (51).  
The assembly of envelope around the nucleocapsid core is the final step in the 
virion maturation pathway. Unlike other enveloped viruses, envelopes in Cystoviridae 
are not picked up during budding but the components are assembled in the host 
cytoplasm. Membrane proteins P9 and P12 are the minimum components required for 
envelopment. The host attachment protein P3 is anchored to the envelope through 
protein P6 and is the last component assembled on to the virion (46). 
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The lysis of the host brings about the end of the infection cycle. The exact 
mechanism of host lysis is not known. It has been suggested that the lytic enzyme P5 in 
the inner core that facilitates PG degradation during infection also plays a role in lysis. 
In addition to P5, a small membrane associated protein P10 was also shown to be 
required for host lysis. It is thought that P10 acts as a holin to release excess intracellular 
P5 into the periplasm, where it degrades PG and causes host lysis (52, 53). The 
mechanism by which P10 facilitates host lysis could represent a new mode of lysis. 
dsRNA phages other than phi6 have been isolated mostly from the leaves of 
plants (54). The phage phi 7, phi9, and phi10 share high degree of sequence identity with 
phi6 but phi8, phi12, and phi13 are quite different from phi6 both in nucleotide and 
amino acid sequence. Structurally these viruses are very similar in appearance but at the 
molecular level there are two major differences between phi6-like and other phages. 
First, phi6 has P6 and P3 to attach to type IV pili while Phi 8 has multiple P3 proteins 
and it attaches to the host LPS. All phages except phi8 have a P8 shell that encapsulates 
the inner core (46). 
Recently Krishnamurthy et.al., have used bioinformatics to identify, among 
others, a novel dsRNA phage from whole cell transcriptome data of a Streptomyces sp. 
This was reported as the first ever RNA phage found for Gram-positive bacteria (55). 
This finding raises the possibility of existence of other RNA phages (both ds and ssRNA 
phages) against other Gram-positive species.  
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ssRNA phages 
The ssRNA phages, the simplest viruses ever discovered, were first isolated as 
male-specific phages of E. coli in 1961 by Loeb and Zinder (56). These are icosahedral 
viruses of 23-28 nm in size that share remarkably similar properties among all the 
known members (57). The capsids have T=3 symmetry with approximately 180 copies 
of coat protein arranged in 20 hexagonal capsomers forming the faces and 12 pentameric 
capsomers occupying the vertices of the capsid. The capsid encloses approximately 4000 
bases of positive-strand ssRNA attached to a single copy of the maturation protein (Mat) 
(58). The ssRNA constitutes about 32% of the total weight of the virus particle. The 
molecular weights of these viruses range from 3.6-3.8 million with sedimentation 
constants ranging from 77-81S (57). Their relative abundance and readily available viral 
polycistronic ssRNA made them an ideal source for messenger RNA to study protein 
translation. This has been one of the most significant contributions of ssRNA phages to 
the field of molecular biology (59). 
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Figure 1.4 Genome organization of prototypical allolevivirus (Q) and levivirus 
(MS2). 
The typical genome organization of the two canonically defined groups of Leviviridae, 
the Allolevivirus Q and the Levivirus MS2. Both Q and MS2 share the same basic 
core three-gene structure of mat, coat, and rep. In Q the maturation gene (A2) is also the 
lysis gene. The product of coat gene in Q is extended at a low frequency as a read-
through product, A1. In contrast, the lysis gene in MS2 has evolved as a separate gene, L. 
The lysis genes are shaded grey. 
 
 
Alloleviviridae and Leviviridae 
The ssRNA phages of the family Leviviridae were grouped into four different 
serological groups viz., Groups I, and II (f2, MS2, R17, fr) and groups III, and IV (Q) 
(60, 61). Based on genome organization, these four groups were later classified in the 
sixth report of the International Committee on Taxonomy of Viruses into Leviviridae, 
Alloleviviridae, and Unclassified Leviviridae (Figure 1.4) (62). 
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Infection, replication, morphogenesis, and release of progeny 
 
The ssRNA phage infection process begins with the attachment of the virion to 
the sides of retractable pili produced by bacteria (63). Although ssRNA phages have 
been found against every retractable pili-like appendage, only coliphages that infect 
through F pili will be discussed below. 
Brinton, Gemski and Carnahan (64) first demonstrated that the presence of F pili 
is necessary for sexual conjugation in various Gram-negative bacteria. The genes for the 
F pilus are carried on the conjugative F plasmid and the cells that carry the F plasmid are 
called F+ (male) cells. The F plasmid, which is ~ 100 kb and carries genes for the DNA 
transfer apparatus, is maintained either as a single-copy plasmid (F+ strains) or as an 
integrated element in the host chromosome (Hfr strains). The F pili are flexible, 
dynamic, filamentous structures that protrude from the surface of male cell, contact the 
F- cell, and allows for transfer of DNA to the female cell (65, 66). The F pilus constitutes 
on average 10,000 monomers of pilin, a processed product of the traA gene. The initial 
product of traA gene is a 121 aa propilin, which gets proteolytically processed after the 
first 51 residues; N-proximal residue of the C-terminal 70 amino acids is acetylated to 
form mature pilin (67).  Mediated by the tra complex, the pilin monomers oligomerize to 
form 1-20 m helical structures with an outer diameter of 8 nm and a 2.5 nm hollow 
core visible in negatively stained electron micrographs (68, 69). Upon contact with a F-  
cell, the pilus retracts to bring both donor and recipient cell in apposition to facilitate the 
transfer of DNA (67). However, cell-to-cell contact is not required for DNA 
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translocation (70). The physical mechanism of DNA transfer and the role of pilus as a 
facilitator or as a DNA conduit are still unknown. 
The ssRNA coliphages adsorb to the sides of F pili through an interaction 
between the attachment protein (A in MS2; A2 in Q) of phage and the pilin (71). This 
interaction is reversible at 4°C; the phage can also reversibly attach to cell-free 
preparations of F pili. However, when attached to cell-associated pili at 37°C the process 
is irreversible (72). An ionic strength of 0.1 M or greater favors maximum phage 
adsorption and is not dependent on the presence of specific cations (73). Mutational 
analysis has revealed that residues 17-28 of the mature pilin form the exposed sides of 
pilus and are involved in phage attachment (74). The F pilus-phage interaction leads to 
cleavage of the Mat protein into two polypeptides, of mass 15 kDa and 24 kDa (74). 
Cleavage of A provides the necessary signal from F pilus to initiate the ejection of RNA 
from the capsid. The mechanism of how a ~1000 nm long RNA genome is unraveled 
from the capsid is unknown. RNA ejection into the cytosol, accompanied by the Mat 
protein, is associated with a rapid decrease in cellular NTP levels (75). It is estimated 
that about 10 phage genomes/cell can enter in the first 5 min of infection (76). The RNA 
entry is dependent of the presence of either Mg+2, Ca+2, Ba+2, or Sr+2 in the medium (77). 
However, it is not known what stage of RNA penetration constitutes the requirement for 
divalent cations.  
The role of the F pilus in the transport of the gRNA has been the subject of 
several models, none of which supported by molecular evidence. Brinton (1965) first 
suggested that RNA was transported through the hollow tube of the F pilus. In support of 
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this model, the hollow core of the pilus is lined by basic residues, which might interact 
with the negative charge of phosphate backbone of the viral nucleic acid (65). Another 
model is the retraction of pili upon attachment of RNA phage (Figure 1.5). The pilus 
retraction proceeds through sequential depolymerization of the pilin subunits at the cell 
cytoplasmic membrane (78). This retraction may bring the phage RNA-Mat complex to 
the base of the pilus to be internalized. Support for this model comes from the 
observation that upon infection with RNA phage PP7, the polar pili of Pseudomonas 
aeruginosa contract by about 50% in length (79). 
Upon entering the cell, the phage RNA functions directly as a mRNA, resulting 
in the synthesis of the viral proteins by the host machinery. Complex regulatory 
elements constituted in the secondary and tertiary structure of the RNA control 
replication and translation of the same RNA molecule. 
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Figure 1.5 ssRNA phage infection cycle  
A generalized schematic of ssRNA phage infection. Host recognition begins with the 
attachment of the Mat protein on the virion to a retractable pilus. The retraction of the 
pilus stimulates the release of the ssRNA genome bound to Mat. The Mat protein is 
cleaved into two fragments and the ssRNA genome bound to two half fragments of Mat 
enter the host through an unknown mechanism. The (strand is synthesized from the (+) 
strand and serves as a template for amplification of more (+) sense strands, which leads 
to increased viral protein synthesis and concurrent assembly of phage particles. Lysis of 
the host terminates the infection cycle.   
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Figure 1.6 Secondary structure of MS2 RNA encompassing 3’ region of coat and 5’ 
regions of L and rep 
Genome map of MS2 is shown in the top right corner with various nucleotide positions 
in the genome are indicated by numbers. The secondary structure of RNA sequence 
between nt 1421 and 1815 is shown with lysis, coat, and operator hair-pins indicated. 
The start and stop codons of three different gene are boxed on the sequence. This figure 
was reprinted from (16). 
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The coat gene is the first of the four phage proteins to be translated as the RNA 
secondary structure occluding the 5’ untranslated region, the initiator “hair-pin”, is 
relatively weak compared to the other genes (Figure 1.6). Translation of coat disrupts the 
base-pairing in an element, the “MJ stem”, upstream of the rep gene, allowing ribosomes 
to initiate translation of the rep cistron. Once Rep is synthesized, the host protein 
ribosomal protein S1, EF-Tu, and EF-Ts form a complex with Rep to form the RNA-
dependent RNA polymerase holoenzyme (RdR). This enzyme complex synthesizes the 
(–) strand by using (+) strand as a template, after which the (–) strand is in turn used as a 
template to synthesize additional (+) strand gRNAs. The RdR initiates (–) strand 
synthesis at the penultimate nucleotide at the 3’ end of (+) strand and ends with copying 
of three G residues at the 5’ end of (+) strand. The (–) strand synthesis is completed by 
the addition of an untemplated A residue at the 3’ end of the (–) strand. This process 
essentially creates the same CCCA 3’ end in the (–) strand as the in the (+) strand. For 
RNA replication, EF-Tu first binds to the 3’ end of (–) strand and recruits the Rep core 
enzyme subunit. Deletional analysis has shown that C-terminal residues of the core 
enzyme also play a role in recognizing the template. The long-distance RNA interactions 
near the 3’ end aid in capture of the 3’ CCCAOH end by the core enzyme to begin RNA 
synthesis. The levels of coat protein control the intracellular levels of Rep. At 
sufficiently high concentration of coat protein, dimers of coat bind to the operator 
hairpin (Figure 1.6) and prevent initiation of new rounds of rep translation. Maturation 
protein is present in single copy per virion so the levels of Mat protein also tightly 
regulated. The SD sequence of mat is normally sequestered in one of the stems of a 5’ 
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clover-leaf-like structure. However, in a nascent (+) strand, because of an intermediary 
“kinetic trap” state, the 5’ structure is slow to reach the equilibrium, thus allowing 
ribosomes to access the SD site and initiate production of Mat. Thus, of the three core 
genes only mat, and rep are under the control RNA regulatory element, whereas coat 
lacks any known regulatory elements. The competition for the S binding site upstream of 
coat gene between ribosomes and replicase (Figure 1.6) acts as the only negative 
regulation for coat expression (16).  
Assembly of the virions begins with the binding of the Mat protein to the (+) 
strand RNA genome (gRNA). This binding primarily happens at the 3’ end (V2 stem 
loop in MS2) (Figure 1.6) of the genome and a secondary site located with the mat gene 
at position 400. Binding of the 3’ end by Mat prevents (–) strand synthesis and initiates 
genome packaging. The second step in assembly is the construction of the capsid around 
the RNA. The capsid nucleation event was thought to be mediated by the operator hair-
pin at the start site of the rep gene (Figure 1.6) (16). Recently Dai et.al., using high-
resolution cryo-EM studies on MS2, have shown that three consecutive stem-loops bind 
to three neighboring coat protein dimers, with the replicase operator being in the middle. 
Additionally, they found that 13 other stem-loops showed a relatively strong interaction 
with the coat dimers and are clustered around the operator hair-pin (80). Although, coat 
protein will form icosahedral capsids in the absence of RNA, the presence of the 
nucleation stem loops significantly enhances the formation of capsids even at low 
concentrations (81).  
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The function of the lysis gene terminates the infection cycle. In MS2, the lysis 
gene, L, is overlaps both coat and rep genes (82). To control the timing of the lysis 
event, translation of L is restricted mainly by the “lysis hair-pin” (Figure 1.6). Unlike the 
translation of rep, the expression of L is not coupled to the translation of the coat gene 
and subsequent unwinding of the hair-pin. Instead, translation of L happens only if the 
coat gene terminates near the L start site. It has been suggested that ribosomes that 
terminate at the coat stop codon drift on the RNA and initiate new round of translation at 
near-by start sites. For MS2, it is estimated that the probability of successful reinitiation 
at the lysis start site is only 5% (16).  
ssRNA phages that infect bacteria other than E. coli 
Given the simplicity of ssRNA phages, it is likely that these viruses initially 
evolved to infect ancestral forms of modern eubacteria. Thus, ssRNA phages could have 
possibly co-evolved to infect every genus of eubacteria. Most the ssRNA phages isolated 
thus far have been those that infect the genus Escherichia. However, there are a few that 
have been isolated against the genera of Acinetobacter, Pseudomonas, and Caulobacter 
(83-85) (Figure 1.7). Among these phages, the ones that infect Caulobacter have been 
classified into three different groups based on serological and species specificities, with 
each group infecting only one of the following three Caulobacter species: bacteroides, 
fuseformis, and crescentus. Irrespective of the type of pili used and the host species that 
ssRNA phages infect, their physical properties are remarkably similar. The virions are 
almost indistinguishable in negatively stained electron micrographs, the diameter of the 
particles ranging from 21-26 nm, and the sedimentation coefficient of virions ranging 
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from 70-88S. By extension, the genomic RNAs from different ssRNA phages also have 
similar sedimentation coefficients of ~ 30S (86). However, subtle morphological 
differences between couple of ssRNA coliphages have been recently elucidated through 
high-resolution cryo-EM asymmetric reconstructions (87) (80). One of the interesting 
features of coat proteins of ssRNA coliphages is the absence of histidine residues (88). 
However, in the case of Caulobacter phage phiCb5, the coat protein lacks methionine 
instead of histidine. An analysis of available phage genomes has revealed that phages 
that infect exclusively Pseudomonas or Acinetobacter have all 20 amino acids. The 
rationale of this unusual phenomenon in the RNA phage infection cycle is not known. 
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Figure 1.7 Evolution of lysis genes at different genomic locations. 
Genome maps of five different phage-types drawn to scale. Lysis genes are highlighted 
in grey.   
 
 26 
 
Cell wall structure and biosynthesis 
A bacterial cell would exist just as a fragile membranous structure of lipids, 
proteins, and nucleic acids if it were not for the high tensile-strength peptidoglycan (PG) 
layer, or the sacculus. This layer allows the cell to tolerate high internal osmotic 
pressures (3-30 atm) and still maintain shape (89). The PG layer is composed of glycan 
strands made up of repeating disaccharide units of MurNAc-pentapeptide and GlucNAc 
(Figure 1.8). In Gram-negative bacteria, this layer is composed of 2-3 glycan strands, 
whereas in Gram-positive bacteria the PG layer has20-80 glycan strands (90-92). Studies 
on the E. coli sacculi show that, on average, a single layer of glycan chains run almost 
perpendicular to the long axis of the cell (93). To provide additional strength, the glycan 
strands are cross-linked through the formation of a peptide bridge between pentapeptide 
side chains of MurNACs of adjacent strands (Figure 1.8). These cross-links make the PG 
layer a very large complex polymer that can be isolated and visualized under an optical 
microscope (92). In Gram-negative bacteria, the PG layer is covalently linked through 
peptide linkages to the Braun’s lipoprotein (Lpp), which is anchored in the inner leaflet 
of OM (91).  
Biosynthesis of PG sacculus can be divided into three different stages: the 
cytoplasmic stage, the membrane stage, and the periplasmic stage.  
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Figure 1.8 Structure of peptidoglycan  
(A) The structure of the disaccharide pentapeptide building block of E. coli glycan 
strands is shown. The dashes on either end represent the repeating units of building 
blocks in a glycan strand. A three-letter code is used for amino acids in the peptide side 
chain. (B) The major peptide crosslink (3-4 linkage) found between glycan strands in E. 
coli is shown. The crosslink occurs between the free amino group of m-DAP of the 
glycan strand (top strand) and the carboxylic acid group of the penultimate D-Ala of 
another glycan strand (bottom strand). The terminal D-Ala of the second strand (bottom 
strand) is lost in the crosslinking reaction. 
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Figure 1.9 The peptidoglycan biosynthesis pathway 
The conserved PG biosynthesis pathway from the modification of UDP-GlcNAc to 
incorporation in periplasmic PG is shown. The enzymes that catalyze each step of the 
reaction are shown next to the arrow. The Lipid II flippase is indicated by a generic blue 
box in the membrane representing both the flippase candidates FtsW and MurJ. The 
undecaprenol lipid carrier is shown as a hair-pin like structure in the bilayer. The PDB 
numbers of the enzyme structures shown in the figure are as follows: MurA (PDB: 
3KR6); MurB (PDB:1MBT); MurC (PDB: 2F00); MurD (PDB: 1E0D); MurE (PDB: 
1E8C); MurF (PDB: 1GG4); MurG (PDB: 1NLM); MraY (PDB: 4J72); MrcA (PDB: 
2C6W). 
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The PG biosynthesis begins in the cytoplasm and it is the transfer of enolpyruvyl 
moiety from phospho-enolpyruvate (PEP) to uridine diphosphate (UDP)-N-
acetylglucosamine (GlcNAc). This step is catalyzed by the essential and highly 
conserved enzyme MurA (94) (Figure 1.9). The structures of MurA from several 
different species has been solved in both free and ligand-bound states (95-97). The 
structures revealed two globular domains that form a clam shell-like structure in the 
apoenzyme state with the active site located in the cleft (open state). Binding of the both 
substrates PEP and UDP-GlcNAc in the cleft brings the two globular domains closer and 
encompasses the substrates to form the catalytically active closed state. The next step in 
PG biosynthesis is the NADPH-dependent reduction of enolpyruvyl UDP-GlcNAc to 
UDP-N-acetylmuramic acid (MurNAc) by the enzyme MurB (98) (Figure 1.9). The next 
series of steps involve sequential ligation of the pentapeptide amino acids to the lactyl 
moiety of UDP-MurNAc. The four Mur ligases (MurC-MurF) catalyze these reactions in 
an ATP-dependent manner. First, MurC catalyzes the addition of L-Ala to UDP-
MurNAc, then MurD adds D-Glu to the product of MurC reaction (UDP-MurNAc-L-
Ala). The third residue in the pentapeptide chain is the unusual amino acid 
mesodiaminopimelic acid (meso-A2pm or mDAP), which is added to the product of 
MurD (UDP-MurNAc-L-Ala-D-Glu) by the enzyme MurE. The MurC-E ligases are 
structurally very similar and have an N-terminal nucleotide-activated substrate binding 
Rossmann-type / fold, a central ATP binding domain, and a C-terminal amino acid 
binding domain, which provides specificity. The binding all three substrates (ATP, 
UDP-MurNAc, and L-Ala/D-Glu/mDAP) occurs in a sequential manner. This sequential 
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binding of the substrates in Mur ligases is essential for forming the high-energy acyl 
phosphate intermediate in the ligation reaction. MurF catalyzes the last cytoplasmic step 
in PG biosynthesis, which is the ligation of D-Ala-D-Ala dipeptide to UDP-MurNAc-L-
Ala-D-Glu-mDAP). Unlike MurC-MurE ligases, MurF lacks the N-terminal Rossmann-
type / domain that binds to nucleotide-activated substrate, instead the nucleotide 
binding function is carried out by the central ATP-binding domain that extends outward. 
The D-Ala-D-Ala substrate synthesis is carried out separately in the cell by an ATP-
dependent D-Ala-D-Ala ligase. The D-Ala is in turn made by racemization of L-Ala by 
an alanine racemase. The final cytoplasmic product of PG biosynthesis is the UDP-
MurNAc-L-Ala-D-Glu-mDAP-D-Ala-D-Ala (UDP-MurNAc-pep5).  
 The first membrane-linked step in PG synthesis begins with the transfer of UDP-
MurNAc-pep5 to the lipid carrier undecaprenyl phosphate (C55-P or UndP) (Figure 1.9).  
This reaction is catalyzed on the cytoplasmic face of the IM by the integral membrane 
protein MraY to generate a product commonly known as Lipid I. MraY has 10 
transmembrane domains, five relatively long cytoplasmic loops, and six periplasmic 
loops (99). However, the crystal structure of MraY from Aquifex aeolicus revealed that 
two of the six periplasmic loops are structured, comprising a -hairpin and an alpha 
helix (100). The catalytic active site, Mg+2, and UDP-MurNAc-pep5 binding sites are in 
a cleft formed by TMDs 5, 3,4,8 and 9b which has access to the cytoplasm. An inverted 
U-shaped groove near TM9b is proposed to the binding site for the Und-P lipid carrier. 
Single-step and two-step mechanisms have been proposed for the catalytic activity 
MraY, but these mechanisms are yet to be confirmed (99). The next lipid-linked step in 
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the pathway is the transfer of GlcNAc from UDP-GlcNAc to the hydroxyl group at 
position C4 of the membrane linked Lipid I to yield Lipid II (Figure 1.9). MurG, a 
soluble protein that functions at the membrane surface, catalyzes this step and follows an 
ordered Bi-Bi mechanism where the enzyme first binds UDP-GlcNAc, then Lipid I is 
recruited to the enzyme to complete the transfer of the sugar. MurG consists of two 
domains linked by a hinge region; the N-terminal domain contains a membrane-
associating hydrophobic region and the Lipid I binding region, while the C-terminal 
domain binds UDP-GlcNAc (98, 99). The Lipid II is flipped across the cytoplasmic 
membrane and the identity of the enzyme(s) that carry out this function has been a 
contentious issue and is covered under the sub-heading “The flippase wars”. 
The extracellular steps of PG biosynthesis utilize the high energy stored in the 
phosphodiester-muramic acid bond of the flipped Lipid II and in the D-Ala-D-Ala 
peptide bond to drive the polymerization and cross-linking reactions respectively. These 
steps are carried out by mono- or bi- functional penicillin binding proteins (PBPs). 
Based on the structure and function of their N-terminal domains, PBPs are divided into 
Class A (bifunctional) and Class B (monofunctional) enzymes. The Class A enzymes 
have a N-terminal proximal glycosyl-transferase (GT) domain and a C-terminal 
transpeptidase (TP) domain. The Class B enzymes have only C-terminal TP domain and 
the N-terminal domain has non-penicillin binding functions. The GT domain catalyze 
the initiation and elongation of Lipid II polymerization. During initiation step, two Lipid 
II monomers are linked b-1,4 linkage between NAM-NAG to form Lipid IV and 
subsequent addition of new Lipid II molecules with the loss of undecaprenyl-
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pyrophosphate elongates the polymer (98). Recently, RodA a member of the SEDS 
superfamily was shown to catalyze GT reactions (101, 102). Although, the extent to 
which RodA drives the GT reactions is not known. The TP domain catalyzes 
transpeptidation to cross-link peptide side chains of adjacent glycan strands. 
Additionally, TP domains catalyze carboxypeptidation reaction to cleave the terminal D-
Ala from the pep5 side chain.  
The “flippase wars” 
After Lipid II is formed in the inner leaflet of IM, it must be flipped to the 
outside of the cell (the periplasm in Gram-negative bacteria) to be incorporated into the 
PG (Figure 1.9). It is estimated that there are only a few hundred Lipid II molecules in 
the cell at any given moment, yet thousands of flipping events per min are needed to 
build the cell wall. In addition, the number of C55-P lipid carriers are also limited 
(~7000 molecules/cell) and are shared by several different pathways (103-107). These 
observations led to a suggestion that Lipid II requires a transporter that rapidly recycles 
the lipid carrier. The identity of this transporter has been sought for decades.  
For several years, FtsW was as the only serious Lipid II flippase contender, 
partly because it fit the genetic criteria viz.: an essential integral membrane protein, 
associated with divisome, interacting with class A (bifunctional) and class B 
(transpeptidase only) penicillin-binding proteins (PBPs).  Moreover, the gene, ftsW was 
localized in a division and cell wall biogenesis gene cluster. Also, the lack of good 
biochemical assays for measuring Lipid II flipping activity, either in vivo or in vitro, 
obscured the confirmatory experiments. The Breukink group developed a FRET-based 
 33 
 
assay and demonstrated that FtsW translocated a Lipid II analog across reconstituted 
liposomes that harbored purified FtsW (108). Based on these experiments it was 
concluded that FtsW is the flippase for septal PG synthesis and its paralog RodA was the 
flippase for cell elongation. Using the same FRET-based assay, two charged residues 
R145 and K153 on TMD4 were shown to be required for translocation of Lipid II (109). 
A pore-like structure within FtsW was suggested to accommodate Lipid II. Apart from 
Lipid II analogues, FtsW was also shown to facilitate transport of different membrane 
phospholipids. However, the charged residues on TMD4 were not required for this 
activity. Based on the in vitro activity of FtsW, it was proposed that other members of 
shape, elongation, division, and sporulation (SEDS) superfamily might also function as 
Lipid II flippases.  
In opposition to the FtsW/RodA hypothesis which was based on in vitro 
biochemical data, Natividad Ruiz used a reductionist bioinformatic approach to identify 
the essential gene, murJ (mviN), as the only Lipid II flippase in E. coli (110).  
Simultaneously, an essential gene screen also identified mviN, another name for murJ, as 
a protein involved in murein synthesis (111). MurJ belongs to a well-characterized 
family of transporters, the multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) 
exporter superfamily. Depletion of MurJ either by a shifting a thermosensitive mutant to 
the restrictive temperature or by turning off an inducible promoter leads to accumulation 
of Lipid II intermediates, nucleotide precursors, loss of cell shape and ultimately lysis. 
MurJ has 14 TMDs with N- and C-termini in the cytoplasm and a central solvent-
exposed cavity which is lined by the transmembrane domains (TMD) TMD1, TMD2, 
 34 
 
TMD7, and TMD8 (112). Charged residues R18, R24, R52, and R270, which lie within 
a solvent-exposed cavity, were found to be essential for MurJ function (113). These 
charged residues are hypothesized to be involved in interaction with Lipid II and 
possibly to facilitate energy coupling during the flipping activity. However, the notion 
that MurJ was the long-sought Lipid II flippase lacked biochemical evidence, until 2014, 
when Sham et al., developed an in vivo flippase assay (114). This assay was based on the 
ability of colicin M (ColM) to specifically cleave periplasmic Lipid II and thereby 
generating a soluble ColM product (Figure 1.10) (115). In E. coli, upon treatment with 
ColM, the periplasmic Lipid II pools are converted into the soluble ColM product, 
proceeding until all the cellular Lipid II molecules are depleted.  In the central 
experiment, when MurJ was chemically inactivated using thiol-modification, Lipid II 
and other nucleotide precursors accumulated inside the cell with a concurrent decrease in 
the ColM product. When this assay was repeated with an E. coli rodA strain depleted of 
FtsW, the ColM product, and thus Lipid II translocation, was unperturbed. This lead the 
authors to conclude that FtsW is not the flippase and, by extension, the SEDS 
superfamily members are not the Lipid II flippases.  
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Figure 1.10 ColM assay for Lipid II flippase activity 
Diagram showing the cleavage of periplasm exposed Lipid II by ColM. The C-terminal 
domain of ColM binds to FhuA and the N-terminal domain gains access to the 
periplasm, presumably through an OM porin. In the periplasm, the N-terminal domain of 
ColM cleaves periplasmic Lipid II into undecaprenol (Und-OH) and soluble 
pyrophosphate-MurNAc-Pep5-GlcNAc, which is processed by periplasmic 
carboxypeptidases to yield pyrophosphate-MurNAc-Pep4-GlcNAc (ColM product). 
Radiolabeled [3H]-mDAP is indicated by a star. 
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MurJ is highly conserved among the Gram-negative bacteria but not in Gram-
positive bacteria. In Firmicutes such as Bacillus, the closet functional homolog of MurJ 
is YtgP.  In B. subtilis, YtgP and other members of the MOP family of proteins (SpoVB, 
YkvU, and YabM) are not essential under laboratory conditions (116). Sporulation 
defects associated with SpoVB null mutants are complemented by E. coli murJ; 
conversely, both spoVB and ytgP can complement a murJ deletion or depletion (117). 
However, deletion of all 10 MOP members in B. subtilis had no significant growth or 
morphological defects, suggesting the existence of an alternate flippase. Subsequently, 
ydaH (renamed as “amj”, for alternate to murJ) was discovered in a synthetic-lethal 
screen with ytgP (118).  Accordingly, the ColM assay was used to show that Amj 
translocated Lipid II; moreover, amj was shown to complement a murJ deletion in E. 
coli.  Unlike MurJ, Amj is predicted have only 6 TMDs and is hypothesized to dimerize 
to form a central cavity to accommodate Lipid II during its translocation. 
The identity of the Lipid II flippase and the mechanism of Lipid II translocation remains 
as the last unresolved mystery in the core PG biosynthesis pathway.  
Lysis strategies of small lytic phages 
Small lytic phages are known to cause lysis of Gram-negative bacterial host 
without comprising a muralytic activity. The lysis proteins of these phages were thus 
termed as “amurins” as they subvert PG without actively degrading the PG meshwork.  
The three canonical amurins and the current knowledge concerning these amurins are 
reviewed below. 
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The E lysis protein of X174 
The first single-gene lysis system to be studied genetically was E of X174, A 
genetic approach was employed to show that the host target of E is MraY (119). This 
genetic data contradicted the previously proposed “membrane tunnel” model by Lubitz 
and coworkers (120) and established a much simpler mechanism of action for E. As 
noted above, MraY is a universally conserved integral membrane protein that catalyzes 
the synthesis of the first lipid linked intermediate (Lipid I) in the pathway for PG 
precursor biosynthesis (104). MraY has 10 transmembrane domains (TMDs) with N-
out/C-out topology (100, 121). E functions as a non-competitive inhibitor of MraY 
(122), thereby inhibiting PG biosynthesis and causing a septal collapse in cells that 
attempt to divide (Figure 1.11). Several mutants of MraY have been isolated with most 
of them being localized to only two (TMD 5 and TMD 9) of the ten TM helices (119, 
122). The first 35 aa of E comprise a hydrophobic domain that is essential for function, 
whereas the last 56 aa are not conserved, highly basic and can be replaced by LacZ or 
other protein domains (123). In addition, the minimal structure of E that can cause lysis 
was determined to be the first 29 residues and within this a minimal 18 residue region 
was found to be critical for function (124). 
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Figure 1.11 E of X174 inhibits the first lipid-linked step in PG biosynthesis  
(A) MraY transfers MurNAc-pentapeptide to the lipid carrier undecaprenol pyro-
phosphate (UndP) to form lipid I. Structure of MraY (PDB: 4J72). (B) The lysis protein 
E inhibits the transfer of MurNAc-pentapeptide to UndP and this leads to an 
accumulation of cytoplasmic PG intermediates and eventual lysis. 
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 Interestingly, E requires a host protein SlyD, to function normally (125). SlyD is 
a FKBP-type peptidyl-prolyl cis-trans isomerase that functions as a protein chaperone in 
E. coli (126). In the absence of SlyD, E is highly unstable, presumably because it fails to 
fold properly (127). Therefore, in the absence of SlyD the host is resistant to E-mediated 
lysis. Indeed, the first host mutants that were isolated as E-resistant mutants were 
deletions in slyD. E mutants that overcame this dependence were isolated by plating 
X174 on lawns on slyD cells and selecting phage mutants that formed plaques. These 
mutants were called Epos for “plates on slyD. Epos mutants R3H and L19F bypassed the 
requirement of slyD due to increased E protein synthesis, although the Epos protein 
remained unstable (128, 129). 
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Figure 1.12 A2 of Q inhibits the first committed step in PG biosynthesis 
The transfer of enol pyruvate moiety from PEP (phospho enol pyruvate) to UDP-
GlcNAc is catalyzed by MurA to form enolpyruvyluridine 5'-diphospho-N-
acetylglucosamine (EP-UDP-GlcNAc). The A2 molecule on a Q virion binds to MurA 
in the closed state, when both PEP and UDP-GlcNAc are bound in the active site. 
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A2 of Q
A similar genetic approach was used to identify the host target of the lysis 
protein A2 of ssRNA phage Q(130). To isolate host rat mutants (resistant to A-two, A2 
was induced from a multicopy plasmid clone and survivors that failed to lyse were 
selected. Survivors in the initial selection were subjected to a second round of screening 
by cross-streaking with Q phage, thus isolating rat mutants. Mapping and subsequent 
sequencing of the resistant locus led to identification of a missense mutation L138Q in 
MurA, the enzyme that catalyzes the committed step in PG biosynthesis (Figure 1.12). 
Inhibition of MurA precludes the synthesis of PG precursors and incorporation of new 
subunits into the growing polypeptide chain, leading to a septal collapse (Figure 1.9). 
Therefore, A2-mediated inhibition of MurA mimics the lysis phenotype of E. During 
lysis effected by expression of A2 or E, [
3H]-DAP incorporation into the SDS insoluble 
material ceases prior to the onset of lysis (130, 131). It was shown that Q particles 
inhibited MurAwt, but not the rat mutant L138Q, in a crude extract; the dissociation 
constant was estimated at ~10 nM (130). Subsequently, in vitro studies with a soluble 
MBP-A2 fusion and MurA suggested that the interaction is direct and dependent on the 
conformation of MurA, preferentially binding to the closed conformational state of 
MurA liganded by both substrates (132). 
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Figure 1.13 L does not affect [3H]-DAP incorporation. 
Cultures with L expressed from an inducible plasmid (squares) or empty plasmid 
(circles). Red symbols show the incorporation of labeled [3H]-mDAP into SDS-insoluble 
material (cpm). Black symbols show growth and lysis monitored by A550 measurements. 
The time points at which [3H]-mDAP and inducer (IPTG) were added are indicated by 
an arrow. This figure was adapted from (133). 
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L of MS2 
In contrast to E and A2, lysis protein L from ssRNA phage MS2 does not inhibit 
[3H]-DAP incorporation into SDS-insoluble material (133) (Figure 1.13). This indicates 
that L does not target any step in PG precursor pathway or the first step of incorporation 
of Lipid II into the murein. In addition, the morphology of lysis mediated by L is 
drastically different. In contrast to E and A2 (which cause septal collapse 
indistinguishable from that observed with cell-wall antibiotics like penicillin (14), L-
mediated lysis is characterized by blebbing along the lateral cell wall (134). Together 
these considerations indicate that L represents a new class of amurin, one that does not 
inhibit PG biosynthesis (Bernhardt 2001, McIntosh 2008). L encodes a 75 aa protein that 
has been reported to be present in the membrane fractions (82). Initial genetic and 
biochemical characterization of L was attempted in the 1980s by the van Duin and 
Holtje groups. It was reported that the highly basic N-terminal half of the protein is 
dispensable for lytic activity but none of the C-terminal truncations were reported to be 
functional (135). An experiment with a synthetic peptide comprising of C-terminal 25 
amino acids of L was reported to dissipate proton motive force (pmf) of E. coli inverted 
membrane vesicles and cause fluorescent dye leakage in reconstituted liposomes (136). 
Additionally, based on immunoelectron microscopy, L was reported to be enriched in 
the zones of adhesion between IM and OM, also known as Bayer’s patches (137). 
Biochemical analysis of the murein in cells in which L-mediated lysis had occurred was 
reported to have a decreased average chain length of glycan strands and altered cross-
linking between them (138). Based on the above observations, van Duin’s group 
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proposed that L causes lesions in the IM and thereby activates host autolytic enzymes 
such as lytic transglycoslyases and D-D endopeptidases to cause rapid lysis (138). 
Although this remains as an attractive model for L function, the experiments with 
synthetic peptide lacked any negative controls and was done in an in vitro system. 
Additionally, the reported localization of L in the Bayer’s patches in all likelihood is 
unlikely as these zones of adhesions are now thought of as an artifact of sample 
preparation for EM imaging (139). Furthermore, L lacks any known signal sequence for 
periplasmic export, suggesting that it is not capable of sorting to periplasmic structures. 
Lysis genes in other phages 
There are 34 sequenced ssRNA genomes are available in the NCBI database 
under the family Leviviridae, which is in turn subdivided into Alloleviviruses, 
Leviviruses, and unclassified Leviviruses. Within these genomes, a large majority of 
them are highly similar in both genetic architectures and nucleotide sequence. Under 
Allolevivirus, there is total of 11 phages but due their extremely high sequence identity, 
five phages (ID2, NL95, SP, TW19, and TW28) are grouped under phage FI and four 
phages (M11, MX1, ST, and VK) are grouped under Q. In effect, there are only two 
Alloleviviruses in the NCBI database.  However, based on the genetic architecture and 
sequence similarity, both could be considered as variants of Q. Similarly, under 
Levivirus there are 20 phages with 9 grouped under BZ13, 7 grouped under MS2, and 4 
unclassified leviviruses. In addition to Allolevivirus and Levivirus, there are 4 
unclassified phages in Leviviridae that cannot be placed into either of the sub-families 
(62).  
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Based on genetic architecture of the lysis gene, all 34 known ssRNA phages can 
be divided into five phage-types: Q, MS2, AP205, and phiCb5. As noted above, in Q 
the Mat gene A2 at the 5’ end of the genome encodes a protein that serves the dual 
function of pili attachment factor and as the lysis protein. In contrast, the lysis gene L in 
MS2 is embedded in alternate reading frames of both coat and rep genes. In the cases of 
phiCb5 and coliphage M, the lysis gene is entirely embedded in the rep gene, although in 
different places (140, 141). The Acinetobacter baumanii phage AP205 has its lysis gene 
separate from the other three genes, located at the5’ end of the genome (83). The diverse 
location of the lysis genes in various RNA phage genomes suggests that lysis genes have 
evolved more than once and probably as a late addition to the genome after speciation to 
different hosts (or to different pili). This diversity in genetic architectures of lysis genes 
also raises the possibility that the underlying mechanism of lysis might also be different. 
Among the RNA phages only the lysis mechanism of A2 from Q has been solved and it 
targets PG biosynthesis enzyme MurA. Given the diversity of single gene lysis (SGL) 
systems and the existence of multiple protein targets in PG biosynthesis and 
maintenance, it is not difficult to imagine the existence of SGL inhibitors for every step 
in PG biosynthesis. 
A recent survey of publicly available RNA-inclusive metagenomes and RNA 
virome studies of invertebrate species have led to the identification of ~200 new ssRNA 
phage genomes (55, 142). Although most of the new genomes are partial, about 80 
genomes are either complete or nearly full-length, with all the three core genes present. 
Some of the new viruses had genomes sizes much larger than all the known Leviviridae. 
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In addition to these core genes, some genomes were found to have additional ORFs of 
unknown function (55). For example, the genome of AVE000 (4.95 kb) has a 1.2 kb ORF 
of unknown function upstream of mat gene and partially overlapping 259 nucleotides of 
mat gene (Figure 1.14). In AVE001 (5.02 kb), the mat gene is unusually large (2.39 kb) 
when compared to mat genes of sequenced leviviruses (range from 1.17-1.60 kb). In a first 
of its kind discovery, AVE002 was found to have an additional nonoverlapping ORF 
between mat and rep genes. One of the genes presumably encodes the coat protein but the 
other could be a novel lysis gene or a gene encoding a capsid component to enlarge the 
size of the virion. Unsurprisingly, only one genome (AVE017) of ~200 genomes had an 
annotated lysis gene. The lysis protein of AVE017 has 38% sequence identity and 43% 
similarity with the L lysis protein of coliphage MS2.  
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Figure 1.14 Genome organization of novel ssRNA phages with new genes and 
genetic architectures.  
The core genes mat, coat, and rep that share similarity with known homologs are shown. 
While the novel genes with no assigned function are indicated with a question mark. The 
genome organization of AVE017 is similar to MS2 and the lysis protein from AVE017 
shares 43% similarity with MS2 L.  
 
 48 
 
CHAPTER II 
MS2 LYSIS OF ESCHERICHIA COLI DEPENDS ON HOST CHAPERONE DNAJ 
Introduction 
The single stranded RNA phage MS2 is one of the simplest viruses, encoding 
just four proteins. Of the four proteins, three of them, RNA-dependent RNA replicase 
(Rep), major capsid protein (Coat), and maturation protein (A) are involved in viral 
replication and assembly. The fourth protein is the lysis protein (L), which causes lysis 
of the host and thus controls the length of infection cycle (14). L was the first gene in 
molecular biology shown to be embedded in two different genes, coat and replicase, in 
this case in the +1 reading frame of each gene (143) (Figure 2.1). Expression of L from a 
plasmid is necessary and sufficient to elicit lysis (135). L is one of the three canonical 
“single gene lysis” systems (SGL) used by small phages to effect lysis, the other two 
being E from the ssDNA phage X174, representing the ubiquitous Microviridae, and A2 
from ssRNA phage Q, representing the Alloleviridae (14). Genetic and molecular 
analysis revealed that both E and A2 inhibit specific steps in the PG biosynthesis 
pathway: A2 inhibits MurA, which catalyzes the first committed step and E inhibits 
MraY, which catalyzes the formation of the first lipid-linked intermediate (119, 130, 
131). In both cases, the isolation of dominant mutations conferring resistance to the 
lethal function of the lysis protein and the mapping of these mutations to the gene 
encoding the biosynthetic enzyme was the key to deciphering the lytic mechanism. In 
the case of E, the first and most common mutations conferring resistance to lysis mapped 
to a different gene, slyD, encoding a cytoplasmic, FKBP-type cis-trans peptidyl-prolyl 
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isomerase (128). These mutations were recessive, however, and subsequent investigation 
revealed that SlyD was required for the stability of E, which has 5 Pro residues in its 91 
aa length. Suppressor mutations in E were all up-translation alleles, compensating for the 
instability of the E protein (129).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Genome organization of X174 and MS2 phages and similarities 
between their lysis proteins.  
Shown are the maps of MS2 and linearized X174 genomes, drawn to scale. The lysis 
genes of the two phages are shaded blue. The lysis gene, L, of MS2 encodes a 75 aa lysis 
protein and the lysis gene E, of X174 encodes a 91 aa protein. The residues spanning 
the TM domain are highlighted in blue. Basic and acidic residues are indicated above the 
primary structure of the lysis proteins.  
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In contrast to E and A2, which have been called “protein antibiotics” because of 
the functional resemblance to cell wall antibacterial agents (14), no clear conceptual 
framework exists for the lytic function of the 75 aa L protein (Fig. 1).  L has a 
hydrophilic N-terminal domain dominated by multiple basic residues and a hydrophobic 
C-terminal domain, presenting an interesting comparison with X174 E (135). Genetic 
analysis had shown that the lytic function of E requires only the N-terminal hydrophobic 
domain and that the highly-charged, basic C-terminal domain could be replaced by 
unrelated sequences including -galactosidase and GFP (42, 119).  Drawing on this 
comparison, the van Duin group showed that expression of N-terminal deletions of L 
retaining as little as 42 C-terminal residues were fully lytic and, indeed, truncations 
retaining only the last 27 residues had partial function (135). Thus, E and L, although 
lacking any sequence similarity, seem to have mirror-image organization of functional 
domains. However, unlike E, induction of L did not lead to a block in PG synthesis, as 
assessed by incorporation of 3H-diaminopimelate (144). Moreover, a synthetic peptide 
corresponding to the C-terminal 25 aa was reported to dissipate proton motive force 
(pmf) of E. coli inverted membrane vesicles and cause fluorescent dye leakage in 
reconstituted liposomes (136). Interestingly, despite the non-essential character of the N-
terminal domain and the absence of any other secretory or membrane localization 
signals, it was reported that L was primarily localized in the periplasmic zones of 
adhesion between IM and OM, also known as Bayer’s patches (137). Moreover, 
biochemical analysis of the murein from cells that had undergone L-mediated lysis was 
reported to have a slightly decreased average chain length of glycan strands and slightly 
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altered cross-linking between them. In addition, L-mediated lysis was blocked in cells 
grown at low pH, where penicillin-induced autolysis was also inhibited. Taken together, 
these results were interpreted as support for a general model where L somehow activates 
host autolytic enzymes, such as lytic transglycoslyases and D-D endopeptidases (138). 
Unfortunately, in the nearly three decades since these studies, no molecular link between 
the putative autolytic response, or indeed any host protein, and L has been established.  
With the aim of identifying host factors involved in L-mediated lysis a genetic 
approach was undertaken. Here, we report the identification of one such factor, the host 
chaperone DnaJ, and the results are discussed in terms of a model for L function and 
regulation. 
Materials and methods 
Culture growth, antibodies, and chemicals 
Unless indicated, LB broth and agar were used as growth medium. When 
indicated, media was supplemented with ampicillin (Amp), kanamycin (Kan), 
chloramphenicol (Cam), and tetracycline (Tet) at concentrations of 100, 40, 10, and 10 
g ml-1 respectively. Growth in liquid cultures and lysis was monitored by measuring at 
A550 as previously described (145). When indicated, isopropyl -D-
thiogalactopyranoside (IPTG) (Research Products International), 5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside (X-Gal), and arabinose were added at a final 
concentration of 1 mM, 10 g/ml and 0.4%, respectively. Primary antibodies against 
MS2 L peptide “TPASTNRRRPFKHEDC” were raised in rabbit (Sigma Genosys), mouse 
anti-His antibodies were purchased from Sigma, and rabbit anti-DnaJ antibodies were 
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Table 2.1 Strains, phages, and plasmids 
Strain, phage, or 
plasmid 
Relevant genotype or 
description 
Reference 
Strains 
  
XL1-Blue recA endA1 gyrA96 thi 
hsdR17 supE44 relA1 lac 
[F’::Tn10 proA+B+lacIq 
Δ(lacZ)M15] 
Stratagene 
MG1655 ilvG- rfb-50 rph-1 (146) 
TB28 MG1655 lacIZYA <>frt (147) 
JW0003 
JW0014 
thrC::kan 
ΔdnaJ::kan 
(148) 
(148) 
RY15784 
RY15177 
RY34179 
F’104 thr-leu leuA::cat 
HfrH lacIq tonA::Tn10 
TB28 ΔdnaJ::kan 
Laboratory strain 
(134) 
This study 
RY34314 TB28 ΔthrC::kan This study 
RY34356 RY34314 thrC+ dnaJP330Q This study 
RY34154 TB28 pKC11  This study 
RY34155 RY34154 [F’::Tn10 
proA+B+lacIq Δ(lacZ)M15] 
This study 
 
 53 
 
 
  
Table 2.1 Continued 
Strain, phage, or 
plasmid 
Relevant genotype or 
description 
Reference 
Phages 
  
MS2 ssRNA phage MS2 Laboratory stock 
pBAD24 bla araC Para (149) 
pRE-L L gene from MS2 cloned 
under the lambda late 
promoter pR' 
(134) 
pUC57-Lsyn 
lacZ 
Synthetic tandem L (Lsyn) 
and lacZ genes cloned 
between EcoRI and HindIII 
GenScript® 
pKC11 bla araC Para::L
syn lacZα This study 
pKC12 bla araC Para::his6 -L
syn This study 
pKC13 bla araC Para::Lodj1 This study 
pKC14 bla araC Para::Lodj2 This study 
pKC15 
pKC16 
bla araC Para::Lodj3 
bla araC Para::his6 -Lodj1 
This study 
This study 
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purchased from Enzo Life Sciences. Secondary Goat anti-mouse-HRP and goat anti-
rabbit-HRP antibodies were purchased from Thermo Scientific. Unless otherwise 
indicated, all chemicals were purchased from Sigma-Aldrich. 
Bacterial strains and bacteriophages  
The bacterial strains and bacteriophages used in this study are described in Table 
2.1 and primers are described in Table 2.2. The dnaJP330Q allele was moved from the Ill1 
mutant into the threonine-auxotroph RY34314 (TB28 thrC::KanR) by P1 transduction 
(150), selecting for growth on M9 minimal agar supplemented with 0.2% glucose (151). 
The dnaJ locus was amplified from Thr+ transductants using primers KC130 and 
KC131and sequenced to confirm the mutation.  The dnaJ merodiploids were constructed 
by mating RY15784 [F’104 thr-leu leuA::CamR] strain with either TB28 or RY34356 
(TB28 thrC+ dnaJP330Q) and selecting exconjugants on LB supplemented with both Kan 
and Cam.  Similarly, RY34155 was constructed by mating RY34154 with XL1-Blue and 
selecting exconjugants on LB supplemented with both Amp and Tet. RY34179 strain 
was constructed by P1 transduction dnaJ::KanR from JW0014. 
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Plasmids 
The plasmids used in this study are in Table 2.1. A DNA fragment containing 
synthetic tandem L (Lsyn) and lacZ genes was cloned under the pBAD promoter in the 
plasmid pBAD24, resulting in the plasmid construct pKC11.  In this construct, both Lsyn 
and lacZ genes were codon-optimized for E. coli expression 
(http://www.idtdna.com/CodonOpt)  and the synthetic DNA with flanking EcoRI and 
HindIII sites at the 5’ end and 3’ was cloned into pUC57 at GenScript®. Using the same 
restriction sites, the synthetic fragment was moved into pBAD24 by standard techniques. 
The plasmid pKC12 was constructed by sub-cloning his6-L from pRE-His6-L (134). The 
Table 2.2 Primers 
Primers Sequence 
KC18 atatatataagcttggatgctttgtgagcaattcg 
KC19 atatatatgaattcaccatggaaacccgattcctcag 
KC30 cggcagaaaagtccacattg 
KC31 cacactaccatcggcgcta 
KC130 ccggtgctgatgcttctgc 
KC131 gcgcttatgggagtgatcc 
KC149 gcatatatgaattcaccatgggcagcagccatcaccatcatca
ccacagccaggatccgtcgaagacaaaaagaagttcaactc 
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DNA of his6-L was PCR-amplified with primers KC18 and KC19, gel purified, digested 
with EcoR1 and HindIII, and cloned into pBAD24. The plasmids pKC13, pKC14, and 
pKC15 were obtained through selection for Lodj alleles (see below). pKC16 was 
constructed by site-directed mutagenesis (SDM) of pKC12 with primer KC149.   
MS2 infection  
Cultures of male strains were grown to A550 ~0.4 and then diluted to 0.1 in 
prewarmed LB medium. Then MS2 lysate was added to the freshly diluted cultures at 
indicated MOIs (multiplicity of infection). 
Ill mutant selection  
Cultures (25 ml) of RY34155 were grown to A550 of 0.2 and induced with 
arabinose.  After ~2 h the lysate was harvested by centrifugation at 10,000 x g for 10 
min. The pellet was washed once with PBS (phosphate buffered saline pH 7.2), and the 
survivors were allowed to recover overnight in 5 ml LB with appropriate antibiotics. The 
induction procedure was repeated and the survivors from the second round of induction 
were serially diluted in PBS and plated on LB agar plates supplemented with appropriate 
antibiotics, IPTG, X-Gal, and arabinose. A total of 6 blue colonies were isolated and 
screened for MS2 phage resistance by using cross-streaks as previously described (119). 
Phage-insensitive isolates were studied further by monitoring lysis phenotypes in 
induced cultures as above. To quantify the expression of L in the mutants, 1 ml sample 
was mixed with 111 l of cold 100% trichloroacetic acid (TCA) as previously described 
(152). The precipitates were collected by centrifugation at 13,000 rpm for 10 min in a 
microcentrifuge. The pellets were washed with 1 ml cold acetone and air-dried. The 
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dried pellets were resuspended in 2X sample loading buffer with -mercaptoethanol and 
boiled for 10 min. Equivalent amounts of protein were analyzed by SDS-PAGE and 
Western blotting as previously described (153). Both primary and secondary antibodies 
were used at 1:3000 dilution. 
DNA sequencing and analysis 
Sequencing for checking cloning and strain construction was done by Eton 
Biosciences (San Diego).  For whole genome sequencing, genomic DNA extracted with 
the Qiagen gDNA kit was used to prepare 250 bp paired-end libraries using the Illumina 
TruSeq Nano DNA LT Library kit (Set A) according to the manufacturer’s instructions.  
Whole genome sequencing was done at the DNA Sequencing Facility of the Institute for 
Cellular and Molecular Biology at UT Austin. The raw sequencing data was processed 
on Mutation Analysis Beta 1 (2014-06-27) available at 
www.cpt.tamu.edu/galaxy/workflow. Briefly, Bowtie2 was used to align the trimmed 
reads to the MG1655 reference sequence (accession number: NC_000913.3). To 
facilitate visual display of single nucleotide polymorphisms (SNP) or 
insertions/deletions (indel), the BAM output from Bowtie2 was processed through 
Mpileup and BCFtools to generate Variant Call Format (VCF), a standardized text file 
format. The SNP/indel variants with QUAL scores >100 in both parental (RY34155) and 
Ill mutants were scored as positive. The positive variants present in Ill mutants but 
absent in parental strain were further characterized. 
 
 
 58 
 
Error-prone PCR mutagenesis and selection for L overcomes dnaJ (LodJ) mutants.  
Error-prone PCR mutagenesis of the L gene was done using GeneMorph II 
Random Mutagenesis kit (Agilent Technologies) per the instructions provided in the kit. 
Briefly, ~900 ng of the L gene template (amplified from pRE-L) was used in the reaction 
with primers KC30 and KC31 to provide ~1 bp change/dsDNA molecule. The randomly 
mutagenized PCR product was gel-purified, digested with EcoRI and HindIII, ligated 
into pBAD24 digested with the same enzymes and electroporated into XL1-Blue. The 
transformants were pooled and the plasmid DNA was extracted using a Qiagen mini-
prep kit to generate a library of L mutants. Plasmids carrying Lodj alleles that restored 
lysis in the dnaJP330Q background were obtained by plasmid release. Briefly, ~100 ng of 
the mutant library was electroporated into RY34356.The transformants were pooled, 
diluted 1: 20,000, grown in 25 ml of LB supplemented with appropriate antibiotics to 
A550 ~0.2 and induced with arabinose. After 50 min, the culture medium was collected 
by centrifugation at 10,000 x g. Twenty mls of the supernatant medium was filtered 
through a 0.22 m syringe filter (VWR) and then passed through a QIAprep 2.0 Spin 
Column (Qiagen). The bound DNA was eluted in 20 l of sterile water. Ten l of the 
released plasmids were retransformed into the same strain and the procedure was 
repeated for another two rounds. At the end of two rounds of amplification, the plasmid 
DNA was extracted and sequenced.  
Pull-down of L and Lodj proteins  
LB cultures (500 ml) of TB28 with appropriate plasmids were grown to A550 
~0.4, induced with arabinose at t=0 and harvested at allele-specific times by rapid 
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cooling in ice and centrifugation at 10,000 x g for 10 min:  20 min (his6Lodj1 allele), 40 
min (L in TB28), and 60 min (L in dnaJP330Q). The cell pellets were resuspended in ~3 
ml PBS supplemented with the P8849 Protease Inhibitor Cocktail (Sigma; 1 l/35 A550 
units original culture) and passed through an Aminco French Pressure cell at 16,000 psi 
three times to lyse the cells. The lysate was centrifuged at 10,000 x g for 10 min to 
remove intact cells. The cleared supernatant was centrifuged at 100,000 x g in TLA 
100.3 rotor (Beckman TL100 centrifuge) to collect membrane fractions. The membrane 
fraction was then resuspended in 1 ml of STE (50 mM Tris pH 8.0, 300 mM NaCl, 1% 
Empigen BB (Fluka), pH 8.0) and incubated overnight at 4°C with gentle mixing. The 
detergent extract was centrifuged at 100,000 x g to separate detergent solubilized 
proteins from detergent-insoluble components. The supernatant (~900 l) was collected, 
mixed with 50 l of Dynabeads® His-tag beads and incubated 5 min at room 
temperature on a roller drum. The binding and elution protocol was followed per 
manufacturer’s instructions except that beads were washed 5 times in STE. A 20 l 
volume from each elution was mixed with 20 l of 2X sample loading buffer, heated at 
100ºC for 10 min, and then analyzed by Western blot. 
Results 
Selection of Ill mutants 
As our first attempt to identify host factors involved in L-mediated lysis, we 
cloned the L gene into a medium copy vector under the control of the lambda late 
promoter, pR’, which in turn is driven by the inducible supply of the lambda late 
activator, Q, from a low copy lac-ara vector. Induction of cells carrying these two 
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plasmids (pQ and pRE-L) results in lysis in approximately the same time as infection by 
phage MS2, with comparable levels of L synthesis (Figure 2.2, 2.3). HfrH cells carrying 
these plasmids were mutagenized with EMS and subjected to two rounds of induced 
lysis before plating for survivor colonies. Of 3,300 colonies screened, 5 were found to be 
Lac+, Q+, MS2R and M13S (134). However, Hfr mapping and P1 transduction revealed 
that all five were recessive missense alleles of pcnB, encoding the polyA polymerase of 
E. coli (Figure 2.2). As expected, the pcnB defect reduced the copy number of the pRE-L 
plasmid to approximately single copy (not shown; (154)), which accounted for the 
survival of these mutants in our inducible plasmid system. Interestingly, these pcnB 
missense mutants were clustered in the polyA polymerase active site (Figure 2.3) and 
conferred dominant resistance to MS2 (Figure 2.2), suggesting a heretofore unsuspected 
role of PcnB in the MS2 infection cycle.   
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Figure 2.2 Expression of L from the dual plasmid system, pQ pRE-L, is sufficient 
for lysis 
 (A) Lysis profile from induction of the dual plasmid system with MS2 L under pR’ 
promoter using 1mM IPTG or 1mM IPTG and 0.2% arabinose (ara) in RY15177 
compared to lysis by MS2 infections of RY15177 at MOI of 5. Cultures were grown at 
37°C.  ●, pQ + IPTG; ■, pRE-L + IPTG; ♦, pQ pRE, + IPTG; ▼, pQ pRE-L, + IPTG; 
▲, pQ pRE-L, +IPTG, +ara; □, pQ pRE-L, uninduced; ○, MS2. (B) pcnB alleles are 
recessive. Induction of plasmid-borne L using IPTG (final concentration of 1mM) at 
time 0. Host and plasmid: ●, pcnB+, vector; ○, pcnB+, pCA24N-pcnB; ■, BMC1, vector; 
□, BMC1, pCA24N-pcnB; ♦, BMC2, vector; ◊, BMC2, pCA24N-pcnB; (C) pcnB alleles 
confer dominant resistance to MS2 infection.  
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Figure 2.2 Continued. Infection of pcnB alleles with MS2 at MOI 5 at time 0.  ●, 
pcnB+, vector; ■, pcnB+, pCA24N-pcnB; ♦, pcnB-, vector; ▲, pcnB-, pCA24N-pcnB; □, 
BMC1, vector; ○, BMC1, pCA24N-pcnB; ∆, BMC2, vector; x, BMC2, pCA24N-pcnB. 
The BMC1 and BMC2 pcnB mutations are defined in the legend to Figure 2.3. This 
figure was adapted from (134). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Plasmid-borne L is expressed at a level comparable to that attained in 
MS2 infected cells.  
 MM represents the molecular mass marker, with sizes in kDa indicated on the left. 
Samples were collected at the indicated times after induction of the plasmids with IPTG 
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Figure 2.3 Continued. (p) or infection with MS2 at an MOI of 5 (MS2).  (B) The 
mutations of pcnB that confer the dominant MS2-insensitivity are shown as missense 
changes in the region defined by residues 72 through 93.  The strains BMC1 and BMC2 
in Figure 2.2 have the allelic changes marked 1 and 2 in panel B. This figure was 
adapted from (134). 
 
 
To avoid host mutants like pcnB that reduce either the plasmid copy number or 
expression of the L gene, we constructed a modified L expression vector, pKC11, with L 
and the lacZ gene in tandem under an ara promoter. This allowed screening for blue 
survivor colonies after L induction. Expression of L from pKC11 was found to cause 
lysis at ~45 min after induction. From approximately 200 survivor colonies screened, 2 
blue colonies with irregular morphology were isolated on X-gal/arabinose plates. Both 
isolates exhibited an absolute plating defect for MS2 (not shown). We next tested the 
kinetics of lysis in liquid culture in comparison with the parental host and found that the 
mutants displayed a 40-50 min delay in the onset of lysis (Figure 2.4). To eliminate the 
possibility that the mutants confer a non-specific resistance to lysis, we tested lysis by E 
of X174 and A2 of Q in the mutant hosts and found no significant delay in either case 
(not shown). Thus, the mutants confer partial resistance specific to L-mediated lysis, 
enough to delay its onset, and were designated Ill mutants (insensitivity to L lysis).   
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Figure 2.4 L-mediated lysis in dnaJP330Q background is delayed and the allele is 
recessive to wild-type. 
(A) The lysis profile of L in wild-type and dnaJP330Q background at 37°C. Cultures were 
grown to A550 ~0.2 and induced with arabinose 0.4% (w/v) final.  Symbols:  ○, TB28 and 
empty vector; ◊, dnaJP330Q and empty vector; □, TB28 and L; X, dnaJP330Q and L. (B and 
C) Same as (A) except the strains are merodiploid for dnaJ and the lysis profiles were 
taken at 30°C (B) and 42°C (C). 
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Figure 2.5 L-mediated lysis in dnaJP330Q and dnaJ backgrounds.  
(A) The lysis profiles of L in wild-type and dnaJP330Q backgrounds at 30°C. Cultures 
were grown to A550 ~0.2 and induced with arabinose 0.4% (w/v) final. (B) Same as (A) 
except the lysis profiles were taken at 42°C. (C) The lysis profile of L in wild-type and 
dnaJ backgrounds at 37°C. ○, TB28 and empty vector; ◊, dnaJP330Q or dnaJ and 
empty vector; □, TB28 and L; X, dnaJP330Q or dnaJ and L. 
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The Ill phenotype is due to a dnaJ mutation 
In order to assign the Ill phenotype to a specific host gene, genomic DNA from 
two Ill mutants was purified and subjected to whole genome sequencing. An analysis of 
the genomic data revealed that both the Ill mutants, which may have been siblings, had a 
P330Q missense mutation in dnaJ. To determine whether the dnaJ mutation was the sole 
factor responsible for the lysis phenotype, the mutation was transduced to a new 
background. The newly constructed dnaJP330Q mutant retained the observed blue-colony 
survivor phenotype of the parental mutant (not shown). Moreover, the dnaJP330Q 
mutation exhibited strictly recessive behavior, with L-mediated lysis fully restored in a 
merodiploid (Figure 2.4). 
Since DnaJ is a heat shock protein (155), we examined the effect of temperature 
on the kinetics of L-mediated lysis in wild type and mutant dnaJ backgrounds.  As 
shown in Figure 2.5, the dnaJP330Q allele exhibited an absolute lysis defect at 30°C, as 
well as significant lysis delays at higher temperatures (Figure 2.5). In addition, the 
dnaJ allele exhibited a more modest delay in lysis when compared with the lysis 
profile in the Ill mutant (Figure 2.5). Immunoblot analysis showed that L accumulation 
paralleled the lysis defect at 37°C and 42°C, but was normal at 30°C in the wild-type 
and dnaJP330Q backgrounds (Figure 2.6).    
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Figure 2.6 L accumulation in dnaJ mutants.  
(A) L accumulation is delayed in dnaJP330Q background when compared to wild-type at 
37°C and 42°C but not at 30°C. (B) L accumulation in wild-type and dnaJ at 37°C 
(bottom). The absence of DnaJ in dnaJ is shown by blotting with anti-DnaJ antibody 
(top). The bands corresponding to L and DnaJ are indicated with an arrow on the right. 
The molecular mass standard in kDa is represented on the left. The time points of sample 
collection are shown directly above the blot. 
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Lodj mutants by-pass DnaJ 
To examine L dependence on DnaJ, we sought suppressors in L that could 
overcome the absolute lysis defect at 30°C in the dnaJP330Q host. To achieve this, we 
used the plasmid release technique (see Methods) to enrich for L alleles with restored 
lytic competence in the mutant background. Plasmid DNAs prepared from individual 
lytic transformants, designated as Lodj (L overcomes dnaJ) alleles, were sequenced. 
Each Lodj mutant plasmid was found to have a single nucleotide deletion that created an 
L gene encoding a protein in which the entire N-terminal half of L was replaced by a few 
N-terminal residues of the Rep protein (Figure 2.7). To verify that Lodj alleles were 
indeed lytically functional, we cloned the new truncated L genes into an inducible 
plasmid and showed that the lysis timing supported by the Lodj alleles was comparable 
in both parental and dnaJP330Q mutants hosts at 30°C as well as 37°C (Figure 2.7). To 
rule out the possibility that it is the presence of the first few amino acid residues of Rep 
that confers the ability to cause lysis in the dnaJP330Q background, we used site-directed 
mutagenesis to replace the first 36 codons of L with His-tag (Figure 2.7), and showed 
that this construct also functions as a Lodj allele (not shown). Taken together, these 
results indicate that it is the presence of the dispensable, N-terminal, highly basic domain 
of L that confers the requirement for DnaJ.   
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Figure 2.7 The Lodj alleles suppress lysis block in dnaJP330Q mutants.  
(A) Primary structure of L aligned with three Lodj proteins and His6-L37-75. Amino acids 
that are different from wild type L are highlighted. (B and C) The lysis profiles of L and 
Lodj1-3 in wild-type and dnaJP330Q backgrounds at 30°C (B) and 37°C (C). ○, TB28 and 
empty vector; □, TB28 and L; , dnaJP330Q and L; ◊, TB28 and Lodj1; X, TB28 and 
Lodj2; ♦, TB28 and LodJ3; ▲, dnaJP330Q and Lodj1; ∆, dnaJP330Q and Lodj2; ■, 
dnaJP330Q and Lodj3. 
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 DnaJ interacts with MS2 L 
To further investigate the role of DnaJ in L-mediated lysis, we asked if DnaJ and 
L formed a complex. We constructed both H6-L and H6-Lodj, encoding L and Lodj 
proteins tagged with an N-terminal hexahistidine sequence, and showed that both were 
fully functional (not shown). Cultures carrying these plasmid-borne alleles were induced 
and membrane extracts prepared from samples taken immediately before lysis. Pull-
down assays using Dynabeads® (see Methods) showed that DnaJ was associated with L 
in the parental cells but not in the dnaJP330Q Ill mutant (Figure 2.8); this association was 
abrogated for the LodJ mutant in both parental and Ill mutant backgrounds. Taken 
together, these results indicate that L and DnaJ form a membrane-associated complex in 
vivo, and that the complex depends on the non-essential N-terminal segment of L 
interacting with the C-terminal domain of DnaJ.  
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Figure 2.8 DnaJ interacts with L but not with Lodj.   
Membrane extracts containing H6-L or H6-Lodj1 were solubilized in detergent were 
bound to anti-his Dynabeads® and the proteins bound to the beads were analyzed by 
Western blotting with anti-DnaJ (top) and anti-His antibodies (bottom). The bands 
corresponding to DnaJ, H6-L, and H6-Lodj1 are indicated by an arrow on the right. The 
molecular mass standards are represented on the left.  
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Discussion 
The Leviviridae, among the most ancient and possibly the simplest known 
viruses, effect rapid and efficient lysis of the host without inhibiting cell wall synthesis 
through the action of the L protein (144). For Gram-negative bacteria, this is the only 
known lysis phenomenon mediated by antibiotics or by phage that does not involve 
either inhibition of PG synthesis or elaboration of a muralytic enzyme by the phage. 
Understanding of how L triggers an autolytic response and identifying the host factors 
involved in the response might reveal an entirely new perspective for novel antibiotics.  
Prior perspectives on L function 
Most of the extant work on L-mediated lysis involved a combination of 
biochemical and electron microscopy analysis of the murein structure in both intact and 
L-lysed bacteria, leading to a model in which L protein localized to the periplasmic 
zones of adhesion and caused the inappropriate activation of cellular autolytic functions 
such as lytic transglycosylases and D-D endopeptidases (137, 138). Moreover, it was 
shown that a defect in membrane-derived oligosaccharide (MDO) biosynthesis provided 
resistance to L-lysis, possibly by impeding appropriate localization of the lysis protein 
(156). However, this model lacked genetic evidence and afforded no clear molecular 
framework that could lead to mechanistic understanding. In addition, the very existence 
of zones of adhesion in growing cells has become controversial, since they have not been 
observed in cryo-electron microscopic images but only in cells that have undergone 
dehydration and fixation for transmission EM (139). Importantly, the MDO-dependency 
was not specific to L-mediated lysis, as the lysis protein E of the ssDNA phage X174 
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displayed a similar dependency (156). At the time, E was also thought to induce 
autolysis (157). However, we have since shown unambiguously that E is a specific 
inhibitor of MraY and causes lysis by inhibiting the biosynthesis of Lipid II (119, 131). 
Thus, it seems likely that the MDO sensitivity of these lysis pathways, one of which 
involves a blockage of PG synthesis and the other does not, is indirect and non-specific.   
The role of DnaJ in L-mediated lysis 
 Here we have taken a genetic approach to identify host factors required for L 
lysis, by the conceptually simple approach of selecting for host mutants resistant to L 
function. The results show that the host chaperone DnaJ is one such factor. We have 
shown that the P330Q missense change in DnaJ, although preserving the essential heat 
shock function of DnaJ, confers a defect in L-mediated lysis, absolute at 30ºC and partial 
at 37ºC. Proline 330 is the most conserved residue in the C-terminal domain of DnaJ, 
present in 689 of the 690 full-length DnaJ sequences from Proteobacter 
(http://eggnog.embl.de/version_3.0/index.html). The one exception, from a 2003 
genomic sequence of S. flexneri, is probably a sequencing error, since more recent S. 
flexneri genomes do not show this variance. Little is known about the biological function 
of the C-terminus. Proline 330 was chosen as the end of the last DnaJ subdomain before 
a putative extreme C-terminal domain that was shown to be required for dimerization of 
DnaJ (158).   
The lysis-defective phenotype of the Ill mutant, dnaJP330Q, is L-specific, with no 
effect on lysis by E or A2, the other two prototypic single gene lysis proteins. Since the 
delayed lysis phenotype is specific for L-mediated lysis and not a general defect, the 
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simplest notion is that the missense change in DnaJ abrogates an important interaction 
between DnaJ and L. This idea is supported by the finding that DnaJ, but not DnaJP330Q, 
co-purifies with his-tagged L.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9 Model for the role of DnaJ in L-mediated lysis.  
DnaJ interacts with highly basic N-terminal domain of L at the membrane, possibly to 
remove steric constraints inhibiting the interaction of L (red) with its target (green). The 
DnaJP330Q variant loses its ability to interact with L, leading to a less stable interaction 
between L and its target, resulting in a delayed and gradual onset of lysis. However, in 
the complete absence of DnaJ, compensatory cellular chaperone activities stabilize the 
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(Figure 2.9 Continued) L-target interaction, resulting in a modest delay in lysis. The 
products of the Lodj alleles lack the N-terminal domain and thus bypass the requirement 
for DnaJ. The thickness of the arrows indicates favorability for complex formation: the 
thicker the arrow, the more favorable the interaction between L and its target. 
 
 
What role does DnaJ play in L-lysis?  It is clearly not the target of L, since 
deletions of the N-terminal domain of L relieve the dependency on DnaJ and restore 
normal L-mediated lysis, indeed the Lodj derivatives, expressed from isogenic plasmid 
environments, evoke lysis much faster than the parental full-length proteins. The 
simplest idea is that DnaJ is required for proper folding of full-length L but not of the 
truncated Lodj proteins. Figure 2.9 shows a cartoon rendition of the model. In the WT 
host, DnaJ interacts with the improperly-folded N-terminal hydrophilic domain, thus 
avoiding a steric clash with a putative cytoplasmic domain of the (still-unknown) target 
protein. Once the complex is formed, DnaJ can dissociate and catalyze further L-target 
events. In support of this notion, there is precedent for DnaJ acting as a chaperone 
independent of the DnaK-ATPase heat shock activity, in stabilizing a Lys/Arg rich C-
terminal domain of TorI, the recombination directionality factor of the KplE1 cryptic 
prophage of E. coli (159). In the dnaJ host, compensatory elevations in other, less-
specific chaperones, would lead to similar folding events, although with slower kinetics 
in the absence of the specific interaction.  By contrast, the Lodj truncations lack the N-
terminal domain and thus do not suffer from the potential steric clash with the target.   
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From this perspective, the parallel with the lysis protein E and the cytoplasmic 
chaperone SlyD is striking. SlyD is absolutely required for the proteolytic stability of E, 
which like L, has a large dispensable domain rich in charged and hydrophilic residues. 
Like L, removal of this dispensable domain also abrogates the chaperone dependence of 
E, although the position of the dispensable domain, at the C-terminus in E and the N-
terminus in L, is opposite in the two lysis proteins. We suggest these dispensable 
domains, evidently requiring chaperone activity for proper folding, have evolved as 
regulatory “damping” features of the two lysis proteins. Among general phage functions 
like genome replication and virion morphogenesis, lysis is distinct in that maximum 
efficiency and speed is undesirable. Moreover, in these simple phages with highly 
constrained genome sizes, both the E and L lysis genes were forced to evolve in alternate 
reading frames of essential genes. It is logical that the smallest possible lytic domain 
would emerge from such evolutionary constraint, and, indeed, the essential segments of 
E and L are the N-terminal 32 and C-terminal 30 residues, respectively. In these severely 
restricted out-of-frame contexts, it would be much less challenging to evolve a highly-
charged region lacking secondary structure and thus compromised in terms of unassisted 
folding. The acquisition of the crippled domain conferred a requirement for interaction 
with a cytoplasmic chaperone and thus provided a context for retarding lysis to allow 
time for assembly of progeny virions. Indeed, this scenario would also confer potential 
for physiological regulation of lysis timing in the E and L systems via the level or 
activity of the respective chaperone. 
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CHAPTER III  
MUTATIONAL ANALYSIS OF THE MS2 LYSIS PROTEIN L 
Introduction 
Small lytic phages with single-stranded nucleic acid chromosomes achieve lysis 
and release of the progeny virions by the expression of a single gene (14). These phages 
can be broadly classified into ssDNA and ssRNA phages. The ssDNA phage X174 is 
the prototype of the ubiquitous family Microviridae, with a 5.4 kb genome and ten 
genes. In the X174 genome, the lysis gene E is entirely embedded the +1 reading frame 
of the essential assembly gene D (22). The ssRNA phages defined the family Leviviridae 
and were traditionally further sub-divided into two genera, Allolevivirus and Levivirus, 
represented by the prototype male-specific coliphages MS2 and Q (Figure 3.1). These 
phages are the simplest viruses, with 3.5- 4.3 kb genomes and three core genes encoding 
an RNA-dependent RNA polymerase or replicase (Rep), a major capsid protein (Coat), 
and Mat, the maturation or attachment protein (one molecule per virion, named as A in 
MS2, A2 in Qβ). The two genera differ in the structure and role of a fourth essential gene 
in each case, with the Alloleviviruses having the A1 gene, a translational read-through 
extension of coat, and the Leviviruses having the L lysis gene, with a reading frame 
overlapping and out-of-frame with the end of coat and the beginning of rep. Moreover, 
the Mat protein of Q (A2) was found to be necessary and sufficient for lysis (160).   
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Figure 3.1 Cysteine scanning and alignment of L homologs identifies the 
importance of the conserved LS motif. 
(A) Genome maps of four ssRNA phages representing the four known genetic 
architectures of lysis genes. The lysis genes are highlighted in grey. (B) Lysis profiles of 
various cysteine scanning mutants. ▲, L; , LC29S; □, LS9C; ◊, LS15C; ♦, LS35C; ▲, LS49C; 
X, LS58C; ○, LL73C. (C) L-like lysis proteins from different leviviruses are aligned with 
respect to the conserved LS motif (yellow), preceded by a stretch of hydrophobic 
residues (underlined) and highly basic N-termini. Basic and acidic residues are 
highlighted in red and blue respectively.  
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The genetic simplicity of the ssDNA and ssRNA phages made it straightforward 
to define the cistron required for lysis. The term amurin has been proposed for these 
lysis proteins, which lack muralytic activity but somehow subvert PG integrity (14). The 
mechanism by which amurins effect lysis remained controversial for decades. One 
model supported by multiple reports was that X174 E formed a “membrane tunnel” that 
traversed the entire envelope and allowed release of the cytosolic contents, including the 
assembled virions (120, 157). Ultimately a genetic approach based on selection of host 
mutants resistant to the induction of the amurin genes cloned under a plasmid-borne 
inducible promoter was successful (119). Remarkably, both the X174 E and Q A2 
amurins were found to be specific inhibitors of enzymes of the conserved pathway for 
murein precursor biosynthesis: A2 inhibits MurA, the first committed step of the 
pathway, whereas E inhibits MraY, which catalyzes the formation of the first lipid-
linked precursor (122, 130, 161). More recently, a Levivirus specific for the 
conjugational pilus of an IncM R-factor was shown to have a lysis cistron, lysM, that 
evolved in a different place in the genome (141). By use of a similar approach, it was 
shown that LysM is a specific inhibitor of MurJ, the Lipid II flippase of E. coli (Chapter 
IV). Thus, for all three of these small phages, the expression of these proteins, either 
from plasmid-cloned cistrons or in the context of phage infection, caused blockage of the 
flow of murein precursors, generally leading to lysis as a result of failed septation 
events. The obvious similarity to murein-specific chemotherapeutic agents has led to 
these lysis proteins being designated as “protein antibiotics” (14). 
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Despite this success with three single gene lysis systems, the function of the 
original amurin, MS2 L, remains unclear. L is a 75 amino acid protein that has been 
reported to be present in the membrane fractions (82). Work from the van Duin group 
using plasmid-borne L genes showed that the highly basic N-terminal half of the protein 
is dispensable for lytic activity, whereas C-terminal truncations were found to be non-
functional (135). An experiment with a synthetic peptide comprising of C-terminal 25 
amino acids of L was reported to dissipate proton motive force (pmf) of E. coli inverted 
membrane vesicles and cause fluorescent dye leakage in reconstituted liposomes (136). 
Surprisingly, immuno-electron microscopy studies using an antibody raised against a 
hybrid L protein, suggested that L was enriched in zones of adhesion between IM and 
OM, also known as Bayer’s bridges (137). Moreover, biochemical analysis of the murein 
in cells lysed by L was reported to have a decreased average chain length of glycan 
strands and altered cross-linking (138). These disparate observations were not easily 
reconciled into a clear conceptual framework. However, it was proposed that L causes 
pmf-depleting lesions in the IM, thereby somehow activating host autolytic enzymes 
such as lytic transglycoslyases and D-D endopeptidases (138). Although this “autolysis” 
remains as an attractive general model for L function, neither an operational schema or 
molecular details for such a pathway have been forthcoming. 
Recently a genetics-based approach, analogous to the approach used for E and 
A2, was employed to address the host target of the L amurin. Although a cellular target 
was not identified, it was demonstrated that the lytic function of L requires an interaction 
with the host chaperone DnaJ, and that this requirement could be bypassed by deletion of 
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the basic N-terminal domain (Chapter II). Here we report a comprehensive genetic 
analysis and identify residues and regions of L that are critical for lysis. Results are 
discussed in terms of a model for L function. 
 
 
 
 
Table 3.1. Strains and plasmids 
Strain and plasmids Relevant genotype or description Reference 
Strains 
  
XL1-Blue recA endA1 gyrA96 thi hsdR17 
supE44 relA1 lac [F’::Tn10 
proA+B+lacIq Δ(lacZ)M15] 
Stratagene 
MG1655 ilvG- rfb-50 rph-1 (146) 
TB28 MG1655 lacIZYA <>frt (147) 
Plasmids 
  
pBAD24 bla araC Para (149) 
pBAD33 cat araC Para (149) 
pQ  (134) 
pRE-L L gene from MS2 clone under the 
lambda late promoter pR' 
(134) 
pRE-LC29S pRE-L with C29S mutation (134) 
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Materials and methods 
Bacterial strains, culture growth, plasmids, and reagents 
The bacterial strains used in this study are described in Table 3.1 and primers are 
listed in Table 3.2. LB broth and LB agar were used as growth medium and were 
supplemented with appropriate antibiotics and inducers. When indicated, ampicillin 
(Amp), chloramphenicol (Cam), and arabinose were added to the growth media at 
concentrations 100, 10 g ml-1, and 0.2-0.4% (w/v) respectively. Bacterial growth and 
lysis were monitored as previously described (145). The his6-Lsyn gene from pKC12 (bla 
araC Para::his6-L
syn) was amplified with primers KC19 and KC30 using Phusion DNA 
 
 
 
Table 3.1 Continued 
Strain and plasmids Relevant genotype or description Reference 
pRE-LC29S, S9C pRE-LC29S with S9C mutation (134) 
pRE-LC29S, S15C pRE-LC29S with S15C mutation (134) 
pRE-LC29S, S35C pRE-LC29S with S35C mutation (134) 
pRE-LC29S, S49C pRE-LC29S with S49C mutation (134) 
pRE-LC29S, S58C pRE-LC29S with S58C mutation (134) 
pKC12 cat araC Para::his6-L
syn (Chapter II) 
pKC17 cat araC Para::his6-L
syn This study 
pBAD24 L bla araC Para::L This study 
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polymerase (New England Biolabs). The PCR product was gel-purified and digested 
with enzymes KpnI and HindIII and ligated into pBAD33 digested with the same 
enzymes to generate pKC17 (cat araC Para::his6-L
syn). Rabbit polyclonal serum raised 
against MS2 L peptide “TPASTNRRRPFKHEDC” and goat anti-rabbit-HRP 
(ThermoFisher Scientific) were used as primary and secondary antibodies respectively. 
Unless otherwise indicated, all chemicals were purchased from Sigma-Aldrich. 
 
 
 
 
 
 
 
 
 
 
Selection of non-functional mutants 
The L gene was randomly mutagenized and cloned into pBAD24 as described in 
Chapter II. The ligated plasmids were transformed into XL1-Blue and plated on LB agar 
plates supplemented with Amp and arabinose. The colonies that survived on the inducer 
plates were picked, grown in liquid culture, the plasmid DNA was extracted using a 
Qiagen mini-prep kit, and the plasmid DNA was sequenced at Eton Biosciences (San 
Diego) with primers KC30 and KC31. The plasmids with a single-missense change in 
Table 3.2 Primers  
       Primer Sequence 
KC19 ATATATATGAATTCACCATGGAAACCCGATTCCTCAG 
KC30 CGGCAGAAAAGTCCACATTG 
KC31 CACACTACCATCGGCGCTA 
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the L gene were transformed into TB28 and the lysis profiles of the mutants were 
compared with that of the wild type allele. The mutants that did not cause lysis in liquid 
culture were scored as non-functional alleles of L.  
Monitoring accumulation of L allele products  
To quantify the expression of mutant alleles of L, 1 ml sample was collected at 
40 min post-induction and mixed with 111 l of cold 100% TCA as previously described 
(153). The TCA precipitates were collected by centrifugation at 13,000 rpm for 10 min 
in a microcentrifuge. The pellets were washed three times with 1 ml cold acetone and 
air-dried. The dried pellets were resuspended in 2X sample loading buffer with -
mercaptoethanol and boiled for 10 min. Normalized amounts of protein (~0.4 A550 units) 
were analyzed by SDS-PAGE and Western blotting as previously described (153). The 
antibodies against MS2 L and goat anti-rabbit-HRP were used at 1:3000 dilution.  
Membrane fractionation 
Cultures of TB28 (500 ml) harboring plasmids with L alleles were grown to an 
A550 ~0.2, induced with arabinose, and the cells were centrifuged at 10,000 x g (Sorvall 
LYNX 6000 Superspeed Centrifuge) for 10 min. The pellets were resuspended in ~3 ml 
PBS (phosphate buffered saline pH 7.2) supplemented with Protease Inhibitor Cocktail 
(Sigma; 1 l/35 A550 units original culture) and the cells were lysed by passing three 
times through an Aminco French Pressure cell at 16,000 psi. The intact cells were 
cleared from the lysate by centrifuging at 10,000 x g and 500 l of the supernatant was 
saved as total fraction. The rest of the supernatant (~2.5 ml) centrifuged at 100,000 x g 
in TLA100.3 rotor (Beckman TL100 centrifuge) for 1 h and the supernatant and 
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membrane pellet were collected. The three fractions were normalized to ~0.4 A550 units, 
mixed with 2X sample loading buffer and boiled at 100°C for 10 min. The samples were 
resolved on SDS-PAGE gels, transferred on to PVDF membranes and Western blotted as 
described in Chapter II.  
Results 
Discovery of a serine residue essential for function allows alignment of diverse L-
like amurins 
In order to facilitate both cysteine-accessibility studies and also experiments with 
heterobifunctional thiol-specific cross-linkers to identify binding partners, we conducted 
site-directed mutagenesis on gene L to create a variety of single-Cys alleles, including 
five Ser-Cys substitutions in the background LC29S where the single natural Cys codon 
was replaced by Ser. Although most of the substitutions had no effect on L lytic 
function, a single change, S49C, conferred an absolute lysis defect, both in the LC29S 
(not shown) and the parental L contexts (Figure 3.1), without affecting L accumulation 
(not shown). We noticed that this essential Ser residue could be used as part of a Leu-Ser 
dipeptide motif for aligning the lysis protein sequences not only from the closely related 
F-specific Leviviruses but also from Leviviruses that use different conjugational or Type 
IV pili for infection (E. coli phages HGAL and C1; Pseudomonas phages PP7 and 
pRR1) and from the A. baumannii phage AP205, where the lysis gene evolved in a 
distinct genomic location (Figure 3.2). These lysis genes have been shown to function in 
E. coli (83, 162, 163). In this alignment, although sequence similarity could not be 
generally detected, organizing the sequences using the LS motif allowed a putative 
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domain structure for L-like amurins to be assigned: (1) a positively charged N-terminus 
(4-36 aa, 3-6 net positive charges); (2) a hydrophobic sequence rich in aromatic and 
large beta-branched aliphatic residues (10 -17 aa); (3) the LS dipeptide; and (4) a phage-
specific C-terminal domain of variable length (4 to 31 residues) but either neutral or 
containing one net charge. Based on the previous truncation analysis of L and our results 
indicating the N-terminal domain confers a dependency on the host DnaJ chaperone, 
Domain 1 would be dispensable (Chapter II).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Mutational analysis of MS2 L.  
The L primary structure is represented same as in Figure 3.1. The four domains of L are 
represented by numbered boxes. Domain 1 in blue is the highly-charged domain of L 
and it is dispensable for function. Domain 2 (brown) is the region composed mainly of 
hydrophobic residues and it is followed by a conserved LS motif (Domain 3). Domain 4 
is variable in length in different L-like proteins. The L-like proteins from phages that 
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(Figure 3.2 Continued) infect through F-pilus all have their Domain 4 (pink) of about 
the same length. While, L- like proteins from phages that infect through pili other than F 
have much shorter C-termini. Missense alleles with lysis defects but without a defect in 
protein accumulation are indicated above the L sequence. Missense changes that do not 
affect lytic function are indicated below the L sequence. Green asterisks indicate all 
possible codon positions where a nonsense mutation could be accessed by a single 
nucleotide change; underlined asterisks indicate positions where no nonsense mutants 
were obtained in the mutagenesis. Basic and acidic residues are highlighted in red and 
blue respectively. The numbers above the primary structure indicate the position of the 
residues within the L protein.  
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Mutant 
number§ 
 Position 
of the 
mutation 
in L 
Base 
pair(s) 
changed 
Amino 
acid(s) 
position 
Amino 
acid(s) 
changed 
Lysis* 
Protein 
levels#  
90  3 GT 1 MI - - 
185  3 GA 1 MI - - 
205  2 TC 1 MT - - 
261  4 GT 2 EStop - N.D. 
190  8 CT 3 TI - - 
223  7 AT 3 TS - - 
326  17 CT 6 PL - - 
127  22 CT  8 QStop - N.D. 
139  24 AT 8 QL - - 
288  23 AT 8 QL - - 
391  31 CT 11 QStop - N.D. 
65  38 CT 13 PL + + 
345  38 CT 13 PL + + 
331  43 TG 15 SA + + 
50  52 AG 18 RG + + 
177  53 GT 18 RI + + 
172  74 AG 25 EG + - 
Table 3.3 Single-missense alleles of L  
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Table 3.3 Continued 
Mutant 
number§ 
 Position 
of the 
mutation 
in L 
Base 
pair(s) 
changed 
Amino 
acid(s) 
position 
Amino 
acid(s) 
changed 
Lysis* 
Protein 
levels#  
291  52 AT 18 RStop - N.D. 
48  55 CA 19 RS + - 
67  56 GA 19 RH + - 
142  58 CT 20 RW + - 
170  58 CT 20 RW + - 
313  59 GT 20 RL + - 
183  67 AG 23 KE + - 
319  67 AG 23 KE + - 
321  67 AT 23 KStop - N.D. 
343  67 AG 23 KE + - 
384  67 AT 23 KStop + N.D. 
46  74 AT 25 EV + - 
172  74 AG 25 EG + - 
184  75 GT 25 ED + - 
300  74 AG 25 EG + - 
301  74 AG 25 EG + - 
302  74 AG 25 EG + - 
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Table 3.3 Continued 
Mutant 
number§ 
 Position 
of the 
mutation 
in L 
Base 
pair(s) 
changed 
Amino 
acid(s) 
position 
Amino 
acid(s) 
changed 
Lysis* 
Protein 
levels#  
307  75 AG 25 EG + - 
308  75 AG 25 EG + - 
309  75 AG 25 EG + - 
317  74 AG 25 EG + - 
322  74 AG 25 EG + - 
323  74 AG 25 EG + - 
324  74 AG 25 EG + - 
327  74 AG 25 EG + - 
192  77 AG 26 DG + - 
157  81 CG 27 YStop - N.D. 
200  87 TA 29 CStop - N.D. 
268  86 GA 29 CR - - 
294  87 TA 29 CStop - N.D. 
77  89 GA 30 RQ + + 
265  89 GT 30 RL + + 
344  88 CT 30 RStop - N.D. 
365  88 CT 30 RStop - N.D. 
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Table 3.3 Continued 
Mutant 
number§ 
 Position 
of the 
mutation 
in L 
Base 
pair(s) 
changed 
Amino 
acid(s) 
position 
Amino 
acid(s) 
changed 
Lysis* 
Protein 
levels#  
166  91 AT 31 RStop - N.D. 
253  91 AT 31 RStop - N.D. 
267  92 GT 31 RI + + 
10  99 AT 33 QH - - 
57  99 AT 33 QH - - 
196  97 AT 33 QStop - N.D. 
361  97 CT 33 QStop - N.D. 
243  100 AT 34 RStop - N.D. 
348  100 AT 34 RStop - N.D. 
213  107 CG 36 SStop - N.D. 
358  107 CA 36 SStop - N.D. 
3  115 TC 39 YH - - 
252  117 TA 39 YStop - N.D. 
356  117 TA 39 YStop - N.D. 
375  119 TA 40 VE - - 
276  122 TA 41 LStop - N.D. 
285  122 TA 41 LStop - N.D. 
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Table 3.3 Continued 
Mutant 
number§ 
 Position 
of the 
mutation 
in L 
Base 
pair(s) 
changed 
Amino 
acid(s) 
position 
Amino 
acid(s) 
changed 
Lysis* 
Protein 
levels#  
290  122 TA 41 LStop - N.D. 
211  127 TC 43 FI - + 
52  130 CG 44 LV - + 
234  131 TC 44 LP + + 
258  131 TC 44 LP + + 
31  133 GC 45 AP + + 
7  137 TA 46 IN - - 
34  136 AT 46 IF + + 
227  137 TA 46 IN - - 
133  140 TA 47 FY - + 
203  140 TA 47 FY - + 
353  140 TA 47 FY - + 
221  143 TC 48 LP - + 
95  146 CT 49 SL - + 
155  146 CA 49 SStop - N.D. 
160  146 CT 49 SL - + 
224  145 TA 49 ST - + 
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Table 3.3 Continued 
Mutant 
number§ 
 Position 
of the 
mutation 
in L 
Base 
pair(s) 
changed 
Amino 
acid(s) 
position 
Amino 
acid(s) 
changed 
Lysis* 
Protein 
levels#  
320  146 CA 49 SStop - N.D. 
2  148 AG 50 KE - + 
106  150 AT 50 KN - + 
118  150 AT 50 KN - + 
187  148 AT 50 KStop - N.D. 
206  149 AT 50 KI - + 
229  150 AT 50 KN - + 
259  148 AC 50 KQ - - 
293  149 AT 50 KI - + 
318  148 AG 50 KE - + 
342  150 AT 50 KN - + 
378  148 AT 50 KStop - N.D. 
383  150 AT 50 KN - + 
396  148 AT 50 KStop - N.D. 
41  152 TC 51 FS - + 
83  152 TC 51 FS - + 
314  155 CA 52 TN - - 
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Table 3.3 Continued 
Mutant 
number§ 
 Position 
of the 
mutation 
in L 
Base 
pair(s) 
changed 
Amino 
acid(s) 
position 
Amino 
acid(s) 
changed 
Lysis* 
Protein 
levels#  
19  158  AG 53 NS - + 
114  157 AG 53 ND - + 
161  157 AC 53 NH - + 
165  158 AG 53 NS - + 
250  158 AT 53 NI - - 
334  159 TA 53 NQ - - 
355  159 TA 53 NK - - 
370  159 TA 53 NQ - - 
107  164 TA 55 LStop - N.D. 
306  164 TA 55 LStop - N.D. 
22  167 TA 56 LH - + 
55  167 TA 56 LH - + 
242  167 TA 56 LH - + 
277  167 TC 56 LP - - 
296  167 TC 56 LP - - 
385  167 TA 56 LH - + 
350  170 TC 57 LP - - 
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Table 3.3 Continued 
Mutant 
number§ 
 Position 
of the 
mutation 
in L 
Base 
pair(s) 
changed 
Amino 
acid(s) 
position 
Amino 
acid(s) 
changed 
Lysis* 
Protein 
levels#  
108  179 TC 60 LP - - 
247  179 TA 60 LQ - - 
304  179 TC 60 LP - - 
372  179 TA 60 LQ - - 
216  188 TA 63 VE - + 
371  188 TA 63 VE - + 
103  197 CA 66 TK - + 
215  197 CG 66 TR - - 
171  205 AT 69 TS - - 
138  211 CT 71 QStop - N.D. 
104  214 CT 72 QStop - N.D. 
84  218 TA 73 LStop - N.D. 
191  218 TA 73 LStop - N.D. 
202  218 TA 73 LStop - N.D. 
§ The number refers to the mutant clone isolate from the selection plates. 
* “+”, indicates lysis in liquid culture, “-”, indicates no lysis in liquid culture. 
# “+”, indicates expression levels of the L allele comparable to WT, “-”, indicates less than WT expression levels. 
N.D. Not determined. 
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Near-saturating mutational analysis for L lytic function    
To interrogate the new L domain structure for functional significance, a 
mutational analysis involving selection for non-lethal L alleles was implemented. The 
general approach was to create a mutagenized library of PCR-mutagenized L alleles in a 
plasmid in which the lysis gene was cloned under a tightly regulated arabinose-inducible 
pBAD promoter (149). The transformants carrying this library were plated for surviving 
cells under inducing conditions. The plasmid DNAs from 396 survivors were extracted 
and sequenced. Several false positives also survived on the inducer plates, probably due 
to the lower concentration of arabinose (0.2% w/v) in the inducer plates. Among the 
false positives 19 were wild-type L, 3 were silent changes, and 34 mutant alleles had no 
lysis defect in liquid culture. All multiple mutation, frameshift and deletion alleles were 
discarded, resulting in a total of 102 lysis-defective, single mutation alleles (Table 3.3). 
A summary of this analysis based on a total of 49 unique single mutation alleles obtained 
from the lysis-defect selection, as well as a mutant allele obtained by site-directed 
mutagenesis, is depicted in Figure 3.2. The mutant hunt was close to saturation, as could 
be judged from the frequency of repeat alleles that were identified late in the procedure. 
Moreover, of 29 possible nonsense mutations that could be accessed by single base 
changes in the L gene, 23 were obtained, distributed throughout the cistron. Generally, 
the mutational analysis supports the domain concept proposed above. Since Domain 1 
has been previously reported to be non-essential, missense alleles in this region 
conferring a lysis defect were not expected.  
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Figure 3.3 Immunoblots of mutant alleles of L.  
The protein samples from various L mutants were collected 5 min prior to the onset of 
lysis, normalized to A550 ~0.4 units, and immunoblotted with anti-L antibody. The wild 
type (WT), empty vector (Vec), and the mutant alleles are indicated directly above each 
blot. The molecular mass standard in kDa is represented on the left. The bands 
corresponding to L are indicated by an arrow on the right.  
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Figure 3.4 L mutant alleles are recessive.  
The lysis profiles of pBAD24 L alleles and pKC17 (his6-L) co-transformants in TB28 
background. The culture growth was monitored by measuring A550, cultures were 
induced at time 0, and A550 of cultures were at indicated time points.  ○, pBAD24 L and 
pKC17; □, pBAD24 LK50E and pKC17; ◊, pBAD24 LL44V and pKC17; X, pBAD24 LF47Y 
and pKC17; ♦, pBAD24 LS49T and pKC17. 
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Accordingly, three of the missense alleles we did obtain in Domain 1 were 
changes to the start codon (M1I, M1T), which ablate L production entirely, and T3I, 
T3S, P6L, Q8L, and C29R, which exhibited a severe accumulation defect (Table 3.3). 
Since the C29S allele is fully functional, we suspect that C29R is also lysis-defective due 
to proteolytic instability, but because this position is within the epitope used for raising 
the antibody, this could not be confirmed. Only one allele, Q33H, was lysis-defective 
and exhibited normal accumulation (Table 3.3 and Figure 3.3). The simplest 
interpretation is that even in the dispensable N-terminal Domain 1, missense changes can 
occur that block function; e.g., by preventing DnaJ from activating L through interaction 
with domain 1. In any case, by far the highest incidence of missense changes with lysis-
defective phenotypes were obtained in the LS dipeptide motif, and in the regions of 
Domains 2 and 4 surrounding the LS sequence, supporting the importance of the motif 
and its context. Moreover, a significant proportion of the inactivating missense changes 
were conservative, especially in terms of hydrophobic and polar character: e.g., L44V, 
F47L, F47Y, S49T (similar to S49C), F51L, and L56F). The inactivating effect of such 
substitutions, coupled with their undiminished levels of protein accumulation (Figure 
3.3) suggests that L makes a specific protein-protein contact that depends on these 
mutationally sensitive residues, rather than acting as a membrane-disrupting peptide as 
previously suggested (136). Most of the other mutations in Domains 2 and 4 more distal 
to the key LS motif represent more drastic changes in side change character. In addition, 
all of the alleles tested were recessive to wild type L, even when the mutant allele was 
expressed from a higher-copy plasmid (Figure 3.4), suggesting that L lytic function does 
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not require homo-oligomerization but instead requires a heterotypic interaction with a 
host protein. Finally, all of the defective alleles tested showed unperturbed association 
with the membrane fraction (Figure 3.5). Taken together, the results of the mutational 
analysis indicate that L has a host membrane protein target and interacts with it through 
the LS motif and the nearby residues in essential Domains 2 and 4. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Both wildtype and mutant alleles of L are membrane-associated.  
The cell lysates from wildtype and mutant alleles (L44V and S49T) were fractionated 
into soluble and membrane fractions by high speed ultracentrifugation. The normalized 
fractions were analyzed by immunoblotting with anti-L antibody. The molecular mass 
standard in kDa is represented on the left. Total (T), soluble (S), and membrane (M) 
fractions are indicated on top.   
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Discussion 
New perspective on L mode of action 
Despite its early identification as the lysis protein in one of the most intensively 
studied phages of all time, MS2 L has long eluded operational or mechanistic 
characterization at the molecular level. Until recently, the extant literature on L focused 
on a consensus in which its essential C-terminal domain acted as a membrane-disrupting 
polypeptide that subverted the energization of the bilayer and somehow induced an 
autolytic response involving unknown host proteins (136). We have interrogated L 
function by genetic analysis based on analysis of survivors of L expression from a 
plasmid vector. First, this approach revealed that the host DnaJ chaperone was required 
for L function, interacting with the N-terminal, highly basic domain of L. Both this 
domain and thus the DnaJ interaction were shown to be dispensable, and a model was 
proposed in which the N-terminus acted as a regulatory domain that inhibited the 
interaction of L with a target protein. In this scenario, then, DnaJ acts not as the target 
but instead binds the regulatory domain and displaces it from its inhibitory position 
(Chapter II). Here, in the next phase of our genetic approach, we have probed the full 
length of the L protein by mutational analysis, revealing a distinct domain structure with 
differential mutational sensitivity and highlighting a dipeptide motif, Leu48-Ser49 that is 
conserved in heterologous amurins. In addition, many of the missense changes found to 
abolish lytic function without affecting accumulation or membrane-localization of L are 
very conservative and indicative of a protein-protein interface. Taken together, the data 
support a model in which the LS motif and its neighboring subdomains form the core of 
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an essential heterotypic protein-protein interaction domain. Moreover, the fact that all 
the inactivating mutations are recessive suggests that L does not act as an oligomeric 
lytic factor, as would be the case for models in which L is proposed to form membrane-
permeating lesions.   
Evolution of L-like amurins  
The study of ssRNA phages began with the F-pilus specific RNA phages of E. 
coli, and indeed the original classification of these Leviviridae into two genera, the 
Leviviruses and Alloleviviruses. This was largely dependent on the fact that the former 
had an independent lysis gene L, overlapping the coat and rep genes, whereas the latter 
did not, instead effecting lysis with a secondary function of the Mat protein (A2 in Q) 
(62, 130). Many Leviviridae, either MS2-like and Q-like based on the arrangement of 
genes, were sequenced, and in all the MS2-like phages, the L sequences were related 
(Figure 3.1). However, more recently the genome sequences of 7 Leviviridae specific for 
other retractable pili have become available, four (PRR1, Hgal1, M and C-1) for 
conjugational pili of R-factor plasmids (141, 162, 163), two for polar pili (PP7 for 
Pseudomonas; phiCb5 for C. crescentus) (140) and one for a Type IV pilus (AP205 for 
A. baumannii) (83). Although there is no significant sequence similarity, the 
arrangements of the genes in PRR1, Hgal1, C-1 and PP7 all resemble that of MS2, with 
a small ORF overlapping the coat-rep gene junction. In each case, the small gene was 
identified as the lysis gene by testing the induction of a plasmid-based clone. However, 
in the other three phages, AP205, M, and phiCb5, there was no ORF at the coat-rep 
junction (83, 140, 141). In AP205 and M, the lysis gene was identified by cloning and 
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testing for inducible lysis, and in both cases, its position was novel: in AP205, it was a 
separate gene at the 5’ end of the genome, whereas in M, it was a gene that is embedded 
out of frame at a different position within rep. Very recently, the lysis protein of the 
latter, LysM, was shown to be an inhibitor of MurJ, the Lipid II flippase of E. coli, and 
thus, operationally, resembles the A2 (Mat) protein of Q, a specific inhibitor of MurA, 
the first enzyme in the peptidoglycan biosynthesis pathway; in both cases, lysis is 
effected by inhibition of cell wall synthesis. The work we have reported here, with the 
identification of the LS motif and the domain structure of L, clearly groups all the lysis 
proteins found encoded at the coat-rep junction and the AP205 lysis protein with MS2 L. 
Moreover, the implication is that the L-mediated pathway to lysis, which operates 
without affecting net cell wall biosynthesis, interacts with a conserved target common to 
these diverse Gram-negative genera. In addition, since the L gene in AP205 is located in 
a completely difference place in the genome compared to the L genes straddling the 
coat-rep boundary, it seems certain that the conservation of the LS motif and the domain 
structure derives from convergent evolution that occurred after speciation of a progenitor 
Leviviridae to the respective retractable pili. This may also be true for the L proteins in 
PRR1, Hgal1, C-1 and PP7, which, although occupying the same coat-rep junction 
region of their respective genomes, share no sequence homology. In support of this 
notion, other work has shown that for MS2, the region of rep within which the key 
hydrophobic and LS elements are encoded in the out of frame L cistron in MS2 is not 
conserved, so the emergence of L-like genes in this region may simply reflect the limited 
availability of genomic space for sequence variation.   
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Comparative analysis of the domain structure of L proteins 
Based on our mutational analysis of MS2 L, we have postulated four domains as 
significant for lytic function of L-like amurins, including the dipeptide sequence LS as a 
completely conserved motif (Figure 3.2). Assuming the LS sequence has to function 
from the same molecular context in all of the L-like proteins, then a comparative 
analysis of the putative domain structured in unrelated L-like amurins may make it 
possible to infer properties of subcellular localization, membrane topology and potential 
target proteins. We have chosen as a comparison set six L sequences from F-specific 
Leviviridae, which we designate as the homologous set, and the five L-like proteins from 
Leviviridae specific for other retractable pili, here designated as the heterologous set 
(Figure 3.1). Confidence for the meaningfulness of this comparison stems from the fact 
that the L sequences from four of the five heterologous phages (Hgal1, C1, AP205 and 
PRR1) have been shown to necessary and sufficient for lysis if induced from a plasmid 
clone in E. coli. Preliminary results from this laboratory have demonstrated similar lytic 
capacity for the cloned L gene of PP7 (Unpublished results, Chamakura, K.R., Tran, J.S., 
and Young, R.F.). 
The simplest conclusions from the alignment pertain to the non-essential Domain 
1, where there are clearly common characteristics for all the L proteins. In all cases, 
Domain 1 is marked by a high content of charged residues, biased towards basic 
residues. Despite a wide variation in size, from 7 residues in AP205 to 36 in MS2 L, 
Domain 1 in all L proteins has a net predicted charge of +3 to +6. The simplest notion is 
that, although L is firmly associated with the membrane, Domain 1 is disposed in the 
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cytosol, consistent with its ability to bind DnaJ. Unstructured basic domains have been 
identified in other amurins (124, 127) and may serve in initial localization to the surface 
of the membrane. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Secondary structure analysis of L and heterologous L sequences. 
 A representative from each of the L sub-groups were chosen and aligned with respect to 
the LS motif (highlighted in yellow). The aligned sequences were then used as input for 
secondary structure prediction on Jpred 4 server (164).  
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The simplest approach to a comparative analysis requires the assumption that 
Domain 1 will prove to be non-essential for the heterologous L proteins. On this basis, 
the alignment of L with the five heterologous L sequences was used for seeding 
secondary structure analysis of L using the Jpred algorithm (164), resulting in a high-
confidence prediction for alpha-helical structure from Leu37 to the C-terminus of the 
molecule (Figure 3.6). This predicted alpha-helical domain coincides exactly with 
Domains 2-4, the essential domains for L function. Moreover, the TMHMM algorithm, 
widely-used for TMD prediction, predicts with uniformly high confidence that L and its 
five functional homologs are integral membrane proteins, which agrees with the 
behavior of L in subcellular fractionation experiments, even when its N-terminal domain 
is in complex with DnaJ (Chapter II) In each case the predicted membrane-embedded 
domain begins at the start of Domain 2 and extends through the LS motif and into 
Domain 4. In addition, a by-product of the L mutagenesis was the isolation of two Pro 
substitution alleles, L44P and A45P, with normal lysis function (Figure 3.2). Although 
proline residues are severe helix-breakers in solvent-exposed structures, they are often 
tolerated at the ends of TMDs (165), suggesting that this domain is embedded in the 
bilayer. Taken together, these considerations suggest a structural model in which all of 
the essential residues in L are in a helical structure that spans the bilayer. However, the 
existence of a TMD is not easily reconciled with the detailed primary structure of the L 
proteins from the F-specific homologous set. In each of these cases, there is a charged 
residue (Lys50 in L) adjacent to the LS motif. Unbalanced charged residues are rarely 
found in TMDs in bacterial integral membrane proteins, except in some transport 
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proteins where there is solvent exposure deep in the membrane-embedded helices 
(166).    
Thus, although MS2 L, and, by extension, the other L proteins are undoubtedly 
membrane proteins, canonical requirements for a simple TMD cannot be met. Moreover, 
even for the heterologous L sequences, where it is not necessary to embed a charged 
residue to accommodate a TMD, the predicted TMD would also place the LS motif 
within the bilayer, where specific interactions presumably including the H-bonding 
capacity of the serine hydroxyl group would be hard to envision unless the membrane is 
unusually distorted. However, recent findings suggest that membrane distortion might be 
integral to normal cell wall growth. To account for homeostatic growth of the PG 
sacculus, models for the recruitment of the PG biosynthetic complexes to sites of 
negative membrane curvature have been proposed and supported by in vivo and in silico 
experiments (167, 168). Disruption of such a system by L interacting with a membrane-
embedded target protein would account for the ability of L proteins to effect lysis 
without inhibiting net incorporation of PG into the existing wall, as has been reported for 
MS2 L (133, 144). Thus interaction of L with its target, perhaps via attraction to 
distorted membrane, would lead to a lytic catastrophe. To address this general 
hypothesis for L lysis, experiments are underway to assess the distribution of L 
molecules relative to the sites of PG biosynthesis. 
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CHAPTER IV 
A VIRAL PROTEIN ANTIBIOTIC INHIBITS LIPID II FLIPPASE 
Introduction 
For bacteriophage infections, the strong cell walls of bacteria, consisting of a 
single highly polymeric molecule of peptidoglycan (PG), pose a formidable barrier to the 
release of progeny virions.  Phage lysis proteins evolved to overcome this barrier can 
point the way to new antibacterial strategies (169). Double-stranded DNA phages of 
Gram-negative hosts employ up to six lysis proteins including the endolysins that 
degrade the PG, but small lytic single-strand DNA (the microviruses) and RNA phages 
(the leviviruses) effect lysis of the bacterial host by expressing a single non-enzymatic 
protein (4, 12, 170).  The two best-studied examples are the A2 protein of levivirus 
(ssRNA phage) Q and the E protein of the canonical microvirus (ssDNA phage) X174 
(119, 130). Because these proteins inhibit specific enzymes in the conserved bacterial 
cell wall synthesis pathway (Figure 4.1) and cause lysis through a septal catastrophe that 
is indistinguishable from that caused by antibiotics directed against these enzymes, A2 
and E have been called “protein antibiotics” (14). The leviviruses, ssRNA phages of 
Gram-negative bacteria, are particularly attractive systems for looking for more of these 
molecules because of their simple three-gene core structure (mat, coat, rep) and 
extremely high mutation rate, leading to a great diversity (Figure 4.1).  
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Figure 4.1 The lysis protein of phage M targets Lipid II flippase.  
(A) The PG precursor pathway, from cytoplasmic UDP-GlcNAc to periplasmic Lipid II, 
with known targets of single gene lysis systems indicated. (B) Genome organization in 
small ssDNA (microvirus X174) and ssRNA (leviviruses Q, MS2, AP205, PhiCb5 
and M) phages.  In the ssRNA phages, the order of essential genes is always mat coat, 
and rep.  mat encodes the maturation or attachment protein, which is present in single 
copy on each virion and is responsible for adsorption to the receptor pilus.   
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Figure 4. 1 Continued. The coat encodes the capsid protein, present in 178 copies and 
encapsidating the single genomic RNA, and rep encodes the viral subunit of the RNA-
dependent RNA polymerase.  In Q, the mat gene is named A2 and has the additional 
function of host lysis.  Lysis genes have evolved in a variety of sites, including within 
essential genes in a different reading frame. (C) Cells with either pBAD24 or pKC3 (lys-
his6 clone) were induced with 0.4% (w/v) arabinose and growth was monitored by 
turbidity. Inset: phase contrast image of cells at the time of lysis (20 min post-induction) 
(scale bar = 5 m). (D) Same as (C), except in hosts with insensitive to M lysis (Iml) 
alleles. 
 
 
Here we show that the lysis protein of levivirus M of E. coli is a specific inhibitor 
of MurJ, which has recently been shown to be the essential flippase that presents the 
final cytoplasmic, lipid-linked PG precursor to the extracellular cell wall biosynthesis 
machinery (114). Since LysM is encoded in an alternate reading frame of the essential 
rep replicase gene (141), this finding indicates that the ssRNA phages have previously 
unappreciated capacity for evolving “protein antibiotics” specific for diverse steps in the 
cell envelope biosynthesis and maintenance pathway. 
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Strain Relevant Genotype Reference 
XL1-Blue 
recA endA1 gyrA96 thi hsdR17 supE44 
relA1 lac [F’::Tn10 proA+B+lacIq 
Δ(lacZ)M15] 
Stratagene 
MC4100 
e14- araD139 Δ(argF-lac)U169 
rspL150(strR) relA1 flhD5301 Δ(fruK-
yeiR)725(fruA25) rbsR22 deoC1 Δ(fimB-
fimE)632(::IS1) 
(171) 
MG1655 ilvG- rfb-50 rph-1 (146) 
TB28 MG1655 lacIZYA <>frt (147) 
NR754 araD+ revertant of MC4100 (172) 
T4112 TB28 lysA763 <>frt This study 
TU276 TB28 lysA763 <>frt This study 
RY34350 T4112 ΔpyrC::kan This study 
RY34351 RY34350 pyrC+murJF64L This study 
RY34352 RY34350 pyrC+murJM233L This study 
RY34363 RY34350 pyrC+murJI248S This study 
RY34366 RY34350 pyrC+murJA59G This study 
RY34376 RY34350 pyrC+murJQ244P This study 
RY34380 RY34350 pyrC+murJV229G This study 
RY34381 RY34350 pyrC+murJI252F This study 
 
 
 
Table 4.1 Strains and plasmids 
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Table 4.1 Continued 
Strain Relevant Genotype Reference 
NR2184 
NR754 ∆murJ ∆hsdR::kan 
(pFLAGMurJ∆Cys/T14C) (112) 
NR2185 
NR754 ∆murJ ∆hsdR::kan 
(pFLAGMurJ∆Cys/A26C) (112) 
NR2202 
NR754 ∆murJ ∆hsdR::kan 
(pFLAGMurJ∆Cys/L3C) (112) 
NR2208 
NR754 ∆murJ ∆hsdR::kan 
(pFLAGMurJ∆Cys/E70C) (112) 
NR2214 
NR754 ∆murJ ∆hsdR::kan 
(pFLAGMurJ∆Cys/A37C)  (112) 
NR2225 
NR754 ∆murJ ∆hsdR::kan 
(pFLAGMurJ∆Cys/V215C) (112) 
NR2285 
NR754 ∆murJ ∆hsdR::kan 
(pFLAGMurJ∆Cys/V281C) (112) 
NR2449 NR754 (pFLAGMurJ∆Cys) (112) 
NR2481 
NR754 ∆murJ ∆hsdR::kan 
(pFLAGMurJ∆Cys/A268C) (112) 
NR2503 
NR754 ∆murJ ∆hsdR::kan 
(pFLAGMurJ∆Cys/L47C) (112) 
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Table 4.1 Continued 
Strain Relevant Genotype Reference 
NR2504 
NR754 ∆murJ ∆hsdR::kan 
(pFLAGMurJ∆Cys/I54C) (112) 
NR3925 
NR754 ∆murJ::FRT 
(pFLAGMurJ∆Cys/F64C) This study 
NR3926 
NR754 ∆murJ::FRT 
(pFLAGMurJ∆Cys/F64L) This study 
NR3927 
NR754 ∆murJ::FRT 
(pFLAGMurJ∆Cys/V229G) This study 
NR3928 
NR754 ∆murJ::FRT 
(pFLAGMurJ∆Cys/M233L) This study 
NR3929 
NR754 ∆murJ::FRT 
(pFLAGMurJ∆Cys/I248S) This study 
NR3930 
NR754 ∆murJ::FRT 
(pFLAGMurJ∆Cys/I252F) This study 
NR3931 
NR754 ∆murJ::FRT 
(pFLAGMurJ∆Cys/Q244P) This study 
NR3932 
NR754 ∆murJ::FRT 
(pFLAGMurJ∆Cys/M233L/I248S) This study 
NR3942 NR754 (pFLAGMurJ∆Cys/V229G/I248S) This study 
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Table 4.1 Continued 
Strain Relevant Genotype Reference 
NR3945 
NR754 ∆murJ::FRT ∆hsdR::kan (pKC6; 
pFLAGMurJ∆Cys/L3C) This study 
NR3946 
NR754 ∆murJ::FRT ∆hsdR::kan (pKC6; 
pFLAGMurJ∆Cys/A37C) This study 
NR3947 
NR754 ∆murJ::FRT ∆hsdR::kan (pKC6; 
pFLAGMurJ∆Cys/V281C) This study 
NR3948 
NR754 ∆murJ::FRT ∆hsdR::kan (pKC6; 
pFLAGMurJ∆Cys/E70C) This study 
NR3949 
NR754 ∆murJ::FRT ∆hsdR::kan (pKC6; 
pFLAGMurJ∆Cys/V215C) This study 
NR3957 
NR754 ∆murJ ∆hsdR::kan (pKC6; 
pFLAGMurJ∆Cys/T14C) This study 
NR3958 
NR754 ∆murJ ∆hsdR::kan (pKC6; 
pFLAGMurJ∆Cys/A26C) This study 
NR3959 
NR754 ∆murJ ∆hsdR::kan (pKC6; 
pFLAGMurJ∆Cys/L47C) This study 
NR3960 
NR754 ∆murJ ∆hsdR::kan (pKC6; 
pFLAGMurJ∆Cys/I54C) This study 
NR3961 
NR754 ∆murJ ∆hsdR::kan (pKC6; 
pFLAGMurJ∆Cys/S259C) This study 
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Table 4.1 Continued 
Strain Relevant Genotype Reference 
NR3962 
NR754 ∆murJ ∆hsdR::kan (pKC6; 
pFLAGMurJ∆Cys/A268C) This study 
   
   
  
 
 
Materials and methods 
Bacterial strains, plasmids and growth conditions  
Primers are listed in Table 4.1.  Cultures were grown with aeration at 37°C in 
lysogeny broth (LB) supplemented with ampicillin (100 g/ml), chloramphenicol (10 or 
25 g/ml), L-arabinose (0.4% w/v), when indicated isopropyl-β-D-thiogalactopyranoside 
(IPTG; RPI) at 25 M or 50 M final concentration were added, and 20 g/ml final 5-
bromo-4-chloro-indolyl-β-D-galactopyranoside (X-Gal) when indicated. All chemicals 
were supplied by Sigma Aldrich unless otherwise indicated. The ΔpyrC::kanR allele was 
obtained from Keio collection (148) and was transduced into appropriate strains by P1 
transduction (150).  
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Primer   Sequence 5'-3' 
KC30 cggcagaaaagtccacattg 
KC31 cacactaccatcggcgcta 
KC163 
cctttggtggataccttcaccaagggcagcagccatcaccatcatc 
accactgataactcgagaagcttggctgttttggcgg 
KC210 cctcctctcgagttatcagtggtg 
KC230 gaataaaccctgtaacatctggcgg 
KC234 accgcatcaggaaccgacgctatatg 
KC238 
ggggcattttcccaggcacttgtaccgattctggcggaat 
ataaaag 
KC247 
ggggcattttcccaggcatgtgtaccgattctggcggaat 
ataaaag 
KC248 gcaatgcgcgtggtgaaacagttgggaccggcgatccttg 
KC249 gccggagcaatgcgcggggtgaaacagatgggaccggc 
KC252 
ccttggcgtctctgtgagcccgatctccttaatcatcaacac 
catttttgc 
KC253 
cgtctctgtgagccagatctccttaagcatcaacaccattttt 
gcctcgtttc 
KC254 
gccagatctccttaatcatcaacaccttttttgcctcgtttct 
tgcttccg 
 
Table 4.2 Primers 
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Table 4.2 Continued 
Primer  Sequence 5'-3' 
KC263 
gccgtatctttgccgaagggggattttcccaggcatttgtacc 
gattctg 
KC264 
gccgtatctttgccgaagggggattttcccaggcattggtacc 
gattctg 
 
 
 
Plasmid pKC3 (bla araC Para::lys-his6 lacZα) encoding a hexahistidine-tagged 
LysM was constructed in multiple steps. First a synthetic construct was obtained 
(Genscript) containing the DNA sequence from phage M (Accession number: 
JX625144) encompassing the lys gene and lacZα, flanked by restriction sites for EcoRI 
and XhoI/HindIII upstream and downstream, respectively, to facilitate cloning, and with 
its start codon changed from TTG to ATG.  This lys construct was sub-cloned into 
pBAD24 between the EcoRI and HindIII sites to yield pKC1. Codons encoding a hexa-
histidine tag were inserted at the 3’ end of lys in pKC1 through site-directed mutagenesis 
with the primer KC163, to generate pKC2. The resulting lys-his6 gene was amplified 
from pKC2 by PCR with primers KC30 and KC210 and Pfu DNA polymerase. The PCR 
product was digested with EcoRI and XhoI and cloned between the corresponding sites 
in pKC1 to yield pKC3. The cloned fragments at each step were verified by sequencing. 
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A lys gene modified at its 3’ end with codons for the c-myc tag 
(GEQKLISEEDLNSAVD) was obtained as part of a gBlock® (IDT) containing flanking 
KpnI and HindIII sites.  Plasmid pKC4 (bla araC para::lys-cmyc) was constructed by 
digesting the gBlock with KpnI and HindIII and ligating the product into the 
corresponding sites in the vector pBAD30. 
Plasmid pKC5 (cat araC para::lys-cmyc) was constructed by sub-cloning lys-
cmyc from pKC4 to pBAD33 with KpnI and HindIII. 
Plasmid pKC6 (bla araC para::lysC10S-cmyc) was constructed similar to pKC4 
where codon for cysteine at position 10 was changed to serine. 
Mutant alleles of murJ were constructed by site-directed mutagenesis into the 
plasmid pFLAGMurJΔCys (112) using Phusion® high-fidelity DNA polymerase (New 
England Biolabs) and primers KC238, KC247, KC248, KC249, KC252, KC253, KC254, 
KC263, and KC264. 
Strains RY34351, RY34352, RY34363, RY34366, RY34376, RY34380, and 
RY34381 carrying Iml mutations were constructed by P1 transduction with Iml mutants 
as donors and RY34350 (lysA:: frt, ΔpyrC::kan) and plated on M9 minimal medium 
supplemented with 0.2% (w/v) glucose and lysine (5 g/ml). The murJ loci from 
transductants were amplified by PCR with primers KC230 and KC234 and the mutations 
confirmed by sequencing. 
Multi-copy suppression  
The E. coli multi-copy (MC) library containing 1- 4 kb fragments of 
chromosomal DNA under para control used in this study was constructed for an earlier 
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work (173).  Approximately 200 ng of pooled MC library and ~100 ng of pKC3 plasmid 
were co-transformed into XL1-Blue by electroporation. The transformants were plated 
on LB-Ara-Amp-IPTG-X-gal plates to select and screen for survivors. The blue colonies 
that appeared on the selection plates were picked and the plasmid DNA was extracted 
using a Qiagen® mini-prep kit. The extracted DNA was digested with HindIII and 
analyzed on 0.8% agarose for 1 h at 95 V to separate pKC3 from MC library plasmid. 
The slower migrating band was gel-purified using a Qiagen® gel-extraction kit, self-
ligated, transformed into XL1-Blue, and selected on LB-chloramphenicol (10 μg/ml) 
plates. The plasmid DNA was extracted with Qiagen® mini-prep kit and the junctions 
were sequenced at Eton Bioscience Inc. with primers KC30 and KC31. The sequence of 
the inserts was mapped to the E. coli MG1655 genome (NC_000913.3) to identify the 
possible suppressors. To rule out the suppressors that interfere with arabinose uptake and 
utilization, the isolates were streaked on M9 minimal agar with arabinose (0.2% w/v) as 
the sole carbon source. 
Selection and screening for insensitive to M lysis (Iml) mutants  
Cultures of XL1-Blue pKC3 were grown to A550 ~ 0.2 and lys was induced with 
arabinose (0.4% w/v). At ~2 hours post-induction, cells were collected from 10 ml of 
culture through centrifugation at 6,000 x g for 10 min, resuspended in 100 l LB, and 
plated on LB-Ara-Amp-IPTG-X-gal plates. The colonies that turned blue after overnight 
incubation at 37°C were picked and streak-purified on the same selection media. The Iml 
mutants thus isolated were further characterized in liquid cultures by following their 
growth post-induction of lys from pKC3. The expression levels of LysM-his6 in Iml 
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mutants were compared with that in wild-type by Western blotting with anti-His (Sigma-
Aldrich). The murJ locus in Iml mutants was amplified by PCR using Phusion® high-
fidelity DNA polymerase (New England Biolabs) with primers KC230 and KC234. The 
amplified PCR product was gel-purified and sequenced with primers KC230, KC231, 
KC234, and KC262.  
Microscopy 
Strain TB28 pKC3 was grown to A550~0.2 and induced with L-arabinose 0.4% 
(w/v). At 20 min post-induction, 1 ml of culture was spun down at 14,000 x g for 30 sec. 
The pellet was resuspended in 20 l, of which 5 l was spotted on a glass slide with 
cover slip on top. Phase contrast images of the cells were taken with a Zeiss AX10 
microscope with 100X oil immersion objective and 100 ms exposure.  
Plasmid retention assay  
TB28 cells carrying plasmids with different mutant alleles of murJ were grown 
to A550 ~ 0.2 and induced with 0.4% arabinose. The cell lysates 1 h post-induction were 
harvested, filter sterilized, and passed through Qiagen® DNA binding columns. The 
bound DNA was eluted with water and transformed into TB28 and the number of 
transformants were counted. The murJ alleles that gave least number of transfromants 
were scored as tight mutants. 
Detecting Lipid II flippase activity with ColM. 
Lipid II flippase assays were done with slight modifications from previously 
described8. Strain RY34351/pKC4, TU276/pFLAGMurJ/pKC4, and 
TU276/pFLAGMurJM233L, I248S/pKC4 were grown in LB supplemented with 0.2% (w/v) 
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glucose, 25 g/ml of chloramphenicol and 15 g/ml ampicillin at 37°C with shaking 
overnight. Cultures were then diluted 1:100 into M9 medium supplemented with 0.2% 
maltose and 100 g of methionine, lysine and threonine and incubated at 37°C with 
shaking. When A600~ 0.3, 15l of [3H]-mDAP (1Ci/l, ARC) was added to 10 ml of 
culture and arabinose was added to a final concentration of 0.4% (w/v) as indicated.  
After 15 minutes, 10 l of colicin M (500 g/ml) was then added to the culture. Cells 
were immediately chilled on ice for 10 min and harvested by centrifugation at 10,000 x g 
for 2 minutes at 4°C. Spent supernatant was discarded carefully, and cell pellets were 
resuspended in 1 ml of hot water and further incubated at 100°C for 30 minutes. Heat-
killed cells and hot water extracts were separated by centrifugation at 100,000 x g for 20 
minutes at 4°C. The supernatant fractions were lyophilized, dissolved in 300µl of buffer 
A (50mM triethylammonium formate pH4.6, 6% (v/v) methanol), followed by HPLC 
with 70 minutes isocratic elution of buffer A on a Nucleosil C18 column (Agilent 
A0119250X046). Radiolabeled soluble PG precursors and ColM products in the eluate 
were detected by inline radioflow detector (Berthold). The hot water extracted cell 
pellets were boiled for 3 minutes in 1ml of water to remove residual water soluble 
radiolabeled compounds. The washed pellets were then resuspended in 100µl of 10mM 
Tris-HCl pH 7.4. Lipid-linked precursors were extracted from the pellet suspension 
twice by adding 100µl of 6M pyridinium acetate/1-butanol (1:2, v/v) followed by 
vortexing. The top butanol fractions were carefully transferred to a new tube after 
centrifugation at 3,000 x g for 30 seconds and washed once with 100µl butanol saturated 
water. Labeled lipid-linked precursors were then quantitated from 100µl of top butanol 
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fractions by scintillation counting in 10 ml of Ecolite scintillation fluid (882745, MP 
biochemicals). 
Complementation test of pFLAGMurJΔCys derivatives 
The ability of pFLAGMurJΔCys-derived plasmids to complement a 
chromosomal ΔmurJ::frt allele was tested as previously described (112) using strain 
NR3267 (NR754 ΔmurJ::frt pRC7KanMurJ)(174). Haploid strains carrying 
complementing pFLAGMurJΔCys-derived plasmids and merodiplod strains NR3942 
(NR754 pFLAGMurJΔCysV229G, I248S) and its wild-type derivative NR2449 (NR754 
pFLAGMurJΔCysV229G, I248S) were processed for western blotting using anti-FLAG M2 
(Sigma-Aldrich) and anti-mouse-HRP (GE Amersham). For immunoblots, cells were 
grown overnight, normalized by OD600, pelleted, and lysed with 50 µl of SCAM lysis 
buffer (5 mM Tris-HCl pH 7.4, 1 % SDS, 6 M urea). Prior to loading onto a 10 % SDS-
polyacrylamide gel, samples were mixed with 50 µl of 2X AB buffer (6.84 mM 
Na2HPO4, 3.16 mM NaH2PO4, 50 mM Tris-HCl pH 6.8, 6 M urea, 1% β-
mercaptoethanol, 3% SDS, 10% glycerol, 0.1% bromophenol blue).  
SCAM  
murJ haploid strains (Table 4.1) carrying ΔmurJ::frt pFLAGMurJΔCys-
derivatives with Cys substitutions at various positions and pKC6 were grown to A600 
~1.0. Production of LysM(C10S)-myc was induced by the addition of 0.2 % L-arabinose 
(w/v). After 10 min at 37oC, cells were pelleted and processed for SCAM as previously 
described (112).  
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In silico MurJ structural modelling  
Renderings of MurJ structural model (112) were generated as previously 
described (114). 
 
 
Multicopy 
suppressor 
5' junction 
start site 
3' junction 
end site 
Full length genes encompassed 
within the cloned fragment 
1 1126096 1129782 yceH-yceM-murJ 
2 1127429 1129782 murJ 
3 112749 1129732 murJ 
4 1616946 1618333 ydeA 
 
  
Table 4.3 Multi-copy suppressor plasmids 
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Figure 4.2 LysM lethality is suppressed by multi-copy plasmids carrying the Lipid II 
flippase gene murJ.  
DNA segments that were present on the multi-copy plasmids that suppressed LysM 
lethality are demarcated by vertical dotted lines.   rimJ = ribosomal-protein-S5-alanine 
N-acetyltransferase; ydeH = diguanylate cyclase; ydeM = predicted anaerobic sulfatase 
maturation enzyme; murJ = lipid II flippase; flgN = flagellar biosynthesis protein; ydeA 
= arabinose exporter; marC = inner membrane protein of unknown function. 
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Results 
Since many leviviruses infect via conjugation pili, they usually can propagate in, 
and thus effect lysis of, diverse bacterial species. Recently, Rumnieks and Tars (2012) 
surveyed the few available ssRNA phage genomes and found that the lysis genes appear 
to have evolved at different sites in the core leviviral genome after speciation of the 
phage to new pili receptors. In particular, they found that levivirus M, which infects via 
the conjugation pilus of IncM antibiotic-resistance plasmids, has its lys gene embedded 
in the +1 reading frame of rep (141). We observed that lysis caused by expression of lys 
cloned in a multicopy plasmid proceeded mostly through septal catastrophes, like A2 and 
E (Figure 4.1), suggesting that the product of lys, LysM, might be an inhibitor of cell wall 
biosynthesis. Next, we used a multicopy library of E. coli genome fragments to look for 
clones that conferred protection against the lethal expression of lys (Figure 4.2, Table 
4.3). Four plasmids were identified, three of which were shown to carry murJ, which has 
been recently shown to encode the long-sought “flippase” that translocate Lipid II across 
the inner membrane in cell wall synthesis (110, 111, 114) (Figure 4.1). A fourth plasmid 
carried ydeA, which encodes a pump that exports cytoplasmic arabinose, the inducer for 
this vector construct (175).  
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Figure 4.3 Only functional murJ alleles rescue cells from LysM lethality.  
TB28 pKC4 (lys-cmyc clone) cells and various pFLAG murJ alleles were induced with 
IPTG (25 M or 50 M) at the beginning of culture growth and 0.4% (w/v) arabinose 
was added at time 0. (A) Chromosomal and (B) plasmid expression of murJ Iml alleles 
rescues cells from lysis. (C) Plasmid expression of murJ Iml double mutants rescues 
cells from lysis except in the case of V229G I248S, which partially rescues cells.  Note 
that an allele in which 5 Iml mutations spanning the entire length of TMD7, fails to 
rescue cells from lysis; this allele is non-functional (not shown). (D) Over-expression of 
wildtype murJ, but not various nonfunctional alleles, rescues cells from lysis. 
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 To isolate MurJ variants that are resistant to LysM, spontaneous chromosomal 
“Iml” mutants (conferring insensitivity to M lysis) were selected using the same lys 
vector and mapped to murJ by P1 transduction.  Each of these murJ mutants survived 
induction of lys expression with no defect in logarithmic growth, whereas the parental 
host underwent complete lysis at ~20 min after induction (Figure 4.1, Figure 4.3).   
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 The Iml mutations mapped to TMD2 and TMD7 of MurJ.  
Structural model of MurJ generated by I-TASSER (112).  The TMDs that line the central 
hydrophilic cavity are colored. The seven Iml mutants identified map to TMDs 2 (light 
blue) and 7 (magenta).  Lateral view (left) and periplasmic view (right). 
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Sequencing of the murJ locus in these 9 mutants revealed seven different single 
missense changes, clustered in two of the fourteen transmembrane domains (TMDs) of 
MurJ, two in TMD2 and 5 in TMD7 (Figure 4.4, Table 4.4).  None of these mutations 
affected accumulation of the MurJ protein (Figure 4.5).   
 
 
 
 
  
murJ Iml 
mutant 
Nucleotide 
change 
Type of change 
Codon 
change 
Amino acid 
change 
1 T→G Transversion GTG→GGG V229G 
2 A→T Transversion ATG→TTG M233L 
3 T→C Transition TTT→CTT F64L 
4 C→G Transversion GCA→GGA A59G 
5 T→G Transversion ATC→AGC I248S 
6 A→T Transversion ATT→TTT I252F 
7 A→C Transversion CAG→CCG Q244P 
8 T→G Transversion ATC→AGC I248S 
9 T→G Transversion ATC→AGC I248S 
Table 4.4 Iml alleles 
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Figure 4.5 Iml MurJ variants are stably produced. 
Anti-FLAG immunoblot was used to determine the effect of Iml mutations on MurJ 
protein levels in whole cells. All Iml MurJ variants were produced from plasmids 
derived from pFLAGMurJΔCys. Functional, plasmid-encoded Iml murJ alleles were 
expressed in cells where the native chromosomal murJ allele was deleted (indicated as 
ΔmurJ below the immunoblot). Non-complementing murJV229G, I248S allele was expressed 
in a strain with a wild-type murJ chromosomal allele (indicated as murJ+ below the 
immunoblot). ΔCys refers to MurJΔCys, a functional variant where the two native 
cysteine residues are substituted by serine residues and which is produced from 
pFLAGMurJΔCys. FLAG-MurJF64L, as previously described for FLAG-MurJ (112), has 
higher mobility than MurJΔCys.   
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Figure 4.6 LysM induces conformational changes in MurJ.  
Substituted-cysteine accessibility method (SCAM) was used to determine whether the 
induction of LysM production changes the conformation of MurJ in the IM. 
Conformational changes were reflected as changes in the exposure of cysteine residues 
introduced at specific positions in MurJ (indicated on the left) to the aqueous periplasm 
or cytoplasm. FLAG tag immunoblotting was used to monitor the mass shift in MurJ that 
the thiol-modifying agent Mal-PEG causes unless cysteines are previously modified by 
IM-permeable NEM (reacts with cysteines exposed to either the periplasm or the 
cytoplasm) or IM-impermeable MTSES (only reacts with periplasmic cysteines). 
Substitutions in green showed no change in SCAM pattern; substitutions in pink showed 
less modification by MTSES and NEM (and therefore more Mal-PEG modification), 
indicating less exposure to the aqueous environment; and substitutions in red showed 
more modification by MTSES and NEM (and therefore less Mal-PEG modification), 
indicating more exposure to the aqueous environment.   
 
L3C
E70C
-LysM +LysM
L47C
MTSES + +
NEM + +
Mal-PEG + + + + + +
V281C
T14C
I54C
A26C
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Chemical probing of MurJ in situ using thiol accessibility (SCAM) provided 
evidence that TMDs 2 and 7, along with TMDs 1 and 8, line a solvent-exposed cavity 
(112), validating a structural model for MurJ generated by I-TASSER (112, 176).  In this 
model, the Iml mutations either map along the same cavity-exposed face of TMD7 or to 
TMD2 near the closed, cytoplasmic interface end of the cavity (Figure 4.4).  We used 
SCAM to address whether LysM affected MurJ conformation in the membrane.  Cys-
substitutions in 11 positions in MurJ were tested for reactivity to the thiol reagents 
MTSES (membrane-impermeable) and NEM (membrane-permeable) in cells in which a 
plasmid clone encoding LysM-cmyc was induced (Figure 4.6). The SCAM patterns of the 
five positions in aqueous domains (N-terminus, two cytoplasmic loops, two periplasmic 
loops) were unaffected by lys  induction, but 5 of the 6 TMD positions exhibited altered 
MTSES sensitivity, with four of the positions being converted from partial to complete 
reactivity. These results suggest that LysM binds to MurJ and causes a conformational 
change; the prevalence of the pattern change showing conversion from partial to 
complete reactivity (positions T14, A26, I54, and V281) suggests that LysM binding 
locks MurJ into one of the two conformations proposed to constitute the Lipid II-flipping 
cycle, with the solvent-filled cavity facing either the periplasm or cytoplasm (112, 113) 
(Figure 4.7).  Further support for this notion derives from inductions of lys in the 
presence of multicopy plasmids carrying non-functional alleles of murJ; despite 
producing normal levels of protein (113), these alleles do not protect the host from 
LysM-dependent lysis, whereas the wild-type allele does (Figure 4.3). 
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Figure 4.7 Model for inhibition of MurJ by LysM.  
(A) Four TMDs (1, 2, 7, and 8) that line the solvent accessible cavity of MurJ13 are 
represented as “V-shaped” rectangle blocks (green) that alternate between cytoplasmic 
and periplasmic exposed conformations. MurJ is proposed to bind to Lipid II in the inner 
leaflet of IM, switch conformations and release Lipid II in the outer leaflet of IM. (B) 
LysM (red) blocks Lipid II flipping activity of MurJ by interacting with TMDs 2 and 7. 
This leads to an accumulation of Lipid II in the inner leaflet of IM, blockage of cell wall 
synthesis, and cell lysis. 
 
  
 
 133 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 LysM blocks Lipid II flipping.  
Cells of ∆lysA strains producing FLAG-tagged MurJ (MurJWT, 
TU192/pFLAGMurJ/pKC4) or its derivative (MurJM233L I248S, TU192/pFLAGMurJM233L 
I248S/pKC4) were labeled with [3H]-mDAP. Arabinose was added at the same time to 
induce the production of LysM as indicated. Colicin M was then added 15 minutes after 
labeling, and growth continued for another 10 minutes.  
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Figure 4.8 Continued. Samples were then withdrawn and either extracted with hot 
water, or sequentially with hot water then butanol. The amount of ColM product was 
measured from hot water extracts by HPLC with an in-line radioflow detector (A). 
Scintillation counting was used to quantify [3H]-mDAP label in the butanol fractions 
(B). Shown are the means ± SEM from three experiments. P values were determined by 
Student’s t test.  Chromatograms of the HPLC results were shown in Figure 4.10. cps, 
counts per second. ***, p<0.001; **, p<0.01; n.s., not significant. 
 
 
Previously, Sham et al., used a colicin M-based assay to show that MurJ 
inhibition blocked Lipid II flipping (114).  When added to the medium of growing cells, 
colicin M invades the periplasm to cleave the undecaprenol carrier from flipped Lipid II, 
generating a soluble disaccharide pentapeptide product that is subsequently converted to 
disaccharide tetrapeptide (ColM product) by periplasmic carboxypeptidases. Thus MurJ 
flippase function can be monitored by the degree to which radiolabeled precursors 
accumulate in the lipid fraction (unflipped Lipid II) and the water-soluble fraction 
(flipped, colicin-cleaved, carboxypeptidase-processed disaccharide tetrapeptide), 
respectively. Using this assay on growing cells carrying the inducible lys construct, we 
showed that expression of lys caused a dramatic accumulation of label in the lipid 
fraction and a corresponding reduction of the soluble ColM product (Figure 4.8 and 
Figure 4.9).  
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Figure 4.9 HPLC chromatograms for detection of ColM degradation products.  
Hot water extracts were prepared from the labeling experiments described in Figure 4.8 
ColM product and other soluble PG precursors were separated from the hot water 
extracts by reverse-phase (RP) HPLC using isocratic elution with 50mM   
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(Figure 4.9 Continued) triethylammonium formate pH 4.6, 6% (v/v) methanol on a 
Nucleosil C18 column followed by detection with inline radioflow detector (Berthold).  
The MurJ variants produced and the indicated treatments were labeled at the right of the 
corresponding chromatograms. Retention times of the labeled peaks were given by 
parentheses.  Quantitation of ColM product (1-pyrophospho-MurNAc(pep4)-GlcNAc) 
was done by measuring the area under the ColM peak, and shown in Figure 4.8. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 MurJF64L confers partial resistance to LysM. 
Although LysM can still inhibit MurJF64L activity, cells expressing MurJF64L have more 
ColM sensitive Lipid II compared to the cells expressing wildtype MurJ. See Figure 4.8 
and Methods for experimental details. 
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Thus, like chemical inactivation of MurJ, LysM blocks Lipid II flipping without 
affecting its biosynthesis. When this assay was repeated with the Iml missense mutant 
murJF64L, partial LysM-mediated inhibition of Lipid II flipping was observed (Figure 
4.10). To further increase resistance to LysM, various double Iml mutations were 
combined. Iml allele murJM233L, I248S was ultimately selected for reduced lysis upon LysM 
induction by plasmid retention assay (see Methods) and by lysis profiles (Figure 4.3). 
When this allele was tested in the colicin M assay, Lipid II flipping was detected even 
when LysM was induced (Figure 4.8). Thus murJ mutations that block lysis after lys 
induction also prevent LysM from inhibiting the MurJ flippase activity. In addition, 
consistent with the hypothesis that LysM inhibits MurJ flippase activity, E. coli cells 
expressing an unrelated Lipid II flippase Amj from Bacillis subtilis (118) are also 
resistant to LysM (Figure 4.11). We therefore conclude that the phage M lysis gene 
encodes a specific inhibitor of MurJ.  
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Figure 4.11 Amj from Bacillus subtilis rescues E. coli from LysM . 
TB28 cells carrying either pKC5 (Para-lys-cmyc cat) alone or with pCS83 (Plac-amj spec) 
were streaked on LB agar plates supplemented with 0.2 % (w/v) glucose (left) or 0.2% 
(w/v) arabinose and 100 M IPTG (right) and incubated at 37°C overnight. 
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   Discussion 
The targeting of MurJ by LysM is the third instance of a single gene lysis system 
targeting an essential step in the peptidoglycan biosynthesis pathway; the other two are 
the X174 E protein, which is a specific, non-competitive inhibitor of MraY (122), and 
Q A2, which inhibits MurA (130, 132).  In each case, no genomic space is dedicated to 
the lysis function.  X174 E is encoded in the +1 reading frame of an essential 
morphogenesis gene (Figure 4.1).  In Q, A2 is the Mat protein, which is present as a 
single molecule on the capsid of all leviviruses, serving to recognize and bind to the F 
pilus.  However, in Q, A2 has evolved an additional ability to bind to and inhibit MurA. 
In phage M, lys has evolved at an entirely new site within the rep gene, again out of 
frame. Thus, like E and A2, Lys
M, the third phage-encoded “protein antibiotic”, occupies 
no dedicated genetic space.  Recent analysis of publicly available metagenomes and 
transcriptomes has revealed that the ssRNA leviviruses are much more ubiquitous and 
diverse than previously appreciated (55, 142), at least in part because many DNA-centric 
metagenomics protocols involve extensive use of RNase during virome sampling. Some 
estimates suggest that in gut samples, RNA phages can represent 10% or more of the 
total virome (177), constituting a deep resource of genomic “dark matter”. Our results 
suggest that the leviviruses, empowered by the extremely error-prone character of their 
RNA-dependent RNA replicase (178), is capable of generating a vast environmental 
library of small proteins that can effect rapid lysis of bacterial hosts by targeting proteins 
involved in building the cell envelope.  The long-neglected genetics of ssRNA phages 
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may be thus turn out to be powerful tools for development of new antibiotics effective 
against resistant bacteria. 
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CHAPTER V 
CONCLUSIONS AND DISCUSSION 
The results presented in this dissertation demonstrate that lysis proteins of small 
lytic phages, especially leviviruses, target different steps in the universally conserved PG 
biosynthesis pathway. Previous work on classic SGL systems, A2 (Q) and E (X174), 
shows them to be specific non-competitive inhibitors of PG biosynthesis enzymes MurA 
and MraY, respectively. In contrast, the molecular understanding of the lysis mechanism 
of L from MS2 has remained elusive, although earlier physiological and biochemical 
experiments indicated that lysis is likely elicited by triggering host autolysis without 
affecting PG biosynthesis (138, 179). The first genetic evidence of a host factor involved 
in the L lysis pathway was provided by the isolation of a dnaJ allele (dnaJP330Q) that 
conferred resistance to L and the demonstration that DnaJ interacted with the N-terminal 
half of L (Chapter II). In the known prokaryotic DnaJ proteins, the proline residue at 
position 330 is the most conserved residue in the C-terminal chaperone and dimerization 
domain of DnaJ. The loss of the N-terminal half of L in LodJ (L overcomes dnaJ) alleles 
abrogates the dependence of L lysis on the presence of DnaJ. The studies presented in 
Chapter II therefore indicate that DnaJ does not play an essential role in the lytic 
mechanism but it might be involved stabilizing the interaction between L and its 
unknown target. The genetic analysis presented in Chapter II is consistent with the 
finding that C-terminal half of L is the lytic determinant, while the N-terminal half 
functions as a regulatory domain controlling the timing of lysis via its interaction with 
DnaJ. Additionally, genetic analysis of L (Chapter III) has revealed that most critical 
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residues for lytic activity are clustered around an LS-dipeptide sequence that includes 
the highly-conserved serine residue at position 49. Even highly conservative changes 
around this region, such as L44V, F47Y, and S49T abolish the lytic activity of L. In 
addition, all the non-functional alleles isolated were recessive; suggesting that L 
functions as a monomer and possibly forms a tight helix-helix interaction with the target 
in the membrane. The LS dipeptide sequence can be found in other SGL proteins 
irrespective of sequence similarity with L, and in all of these systems the LS sequence 
demarcates the C-terminus of a hydrophobic oligopeptide sequence. 
To determine if other ssRNA phages target PG biosynthesis enzymes other than 
MurA, we performed genetic and biochemical analysis of the mechanism of LysM (E. 
coli phage M)-induced lysis (Chapter IV). In these studies, multi-copy suppressor 
plasmids carrying E. coli chromosomal fragments encompassing murJ, the lipid II 
flippase, gene were isolated. Additionally, one isolate carried a chromosomal fragment 
encompassing the gene ydeA, an arabinose efflux pump. Furthermore, nine Insensitive to 
M lysis (Iml) mutants were isolated, of which, seven were unique changes that mapped 
to 2 out of 14 TMDs of MurJ. Of the seven, two mapped to TMD2 and five to TMD7. 
LysM-mediated lysis can be blocked by overexpression of functional MurJ as variants 
murJR18A, murJR24A, and murJR270A were unable to rescue cells from lysis. Lys
M inhibition 
of MurJ was demonstrated in vivo by my collaborator L-T. Sham using a colicin M-
based Lipid II flippase assay, providing further evidence to support the claim that MurJ 
is the sole Lipid II flippase in E. coli. Thus, in addition to A2 and E, Lys
M also functions 
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as an inhibitor of cell wall biosynthesis, but instead of targeting the first committed step 
or first lipid-linked step, it targets the last lipid-linked cytoplasmic step of PG synthesis. 
Current and future work on SGLs and ssRNA phages 
L-mediated lysis 
The molecular mechanism of L-mediated lysis is still not known. The prevailing 
operational model, that L activates a mysterious host autolytic response, was proposed 
by Holtje and van Duin in 1989 and still stands. However, neither the identity of the host 
target nor molecular details of the putative autolysis has been determined, despite 
multiple attempts with genetic and biochemical approaches. In this study, two genetic 
approaches were employed. First, spontaneous host mutants that are insensitive to LodJ 
were selected and two mutant candidates were isolated from 50 independent 
experiments. However, in both candidates the LodJ gene on the plasmid was disrupted 
by a nonsense mutation or by the insertion of a transposon. The fact that these extremely 
rare plasmid segregants were isolated, rather than mutations in the L target, points to the 
idea that the L interaction site on the target is either essential or is very small, possibly 
one or two residues. The second approach involved selecting suppressors of L-mediated 
lysis from a library of E. coli chromosomal fragments in a multi-copy plasmid platform. 
All the suppressors that were isolated carried chromosomal fragments encompassing the 
gene ydeA, an arabinose efflux pump. YdeA was probably pumping out the inducer and 
conferred resistance to L lysis. The genetic analysis of L combined with the difficulty in 
obtaining host mutants resistant to L suggest that either the target or the target-L 
interaction site is over-determined. One approach to circumvent this problem is to 
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identify evolutionarily distant L-like proteins that are functional in E. coli and employ 
such genes in genetic selections to identify the target. The L-like candidates from 
Pseudomonas (PP7 and PRR1) and Acinetobacter (AP205) phages could provide a 
promising start in this regard. The lysis protein from AP205, a 35 aa peptide, is 
particularly interesting as it evolved in a completely new genomic location at the 5’ end 
of the viral genome, rather than at the usual coat-rep junction. Another approach is to 
block L-mediated lysis with multi-copy suppressor plasmids harboring chromosomal 
fragments from an evolutionarily distant host. Along similar lines a genetic approach 
that may be worth pursuing is multi-copy suppression with environmental DNA 
(eDNA), DNA isolated from microbes in the soil. In this scenario, heterologous 
expression of an evolutionarily distant target from eDNA cosmid library would protect 
E. coli from L-mediated lysis and thus aid in identifying the homologous target in E. 
coli. 
phiCb5 lysis gene 
The lysis gene of Caulobacter crescentus ssRNA phage phiCb5 has evolved as 
an embedded gene in the +1 reading frame of rep (Figure 1.7). The genomic location of 
the lysis gene mirrors that of phage M yet the protein shares many features with E from 
X174. There is no sequence similarity between LysphiCb5 and E, but the two proteins 
share features such as N-out, C-in membrane topology, a highly basic and proline-rich 
C-terminus, and a short N-terminus (Figure 5.1). The striking similarity in domain 
architecture despite unrelated primary structures between the two suggests the possibility 
that LysphiCb5 has independently evolved to target MraY. The high mutation rates in 
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ssRNA phages, lack of a DNA stage in RNA replication, and lack of RNA 
recombination mechanisms all point to an independent evolution event. However, 
expression of LysphiCb5 in E. coli does not cause lysis.  
To determine if LysphiCb5 targets Caulobacter MraY, an E. coli strain with its 
native mraY gene replaced with Caulobacter crescentus mraY is currently being 
constructed. LysphiCb5-mediated lysis in this strain would suggest that the target is MraY. 
Additionally, this strain could be used to isolate mutations that confer resistance to 
LysphiCb5 and thus map the interface between the two proteins. If LysphiCb5 targets MraY 
it would be interesting to see if the TMDs targeted by are the same as E (TMDs 5 and 9). 
The striking similarity with E also raises some interesting questions; for example, is the 
C-terminal domain required for lysis? Additionally, it would be interesting to assess 
whether LysphiCb5 requires the C. crescentus equivalent of SlyD, as a potential regulatory 
interaction.  
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Figure 5.1 The similarity between X174 E and LysPhiCb5 lysis proteins. 
The primary structures of E and LysPhiCb5 are shown (top). The basic and acidic residues 
are indicated above the primary structure by + and – symbols respectively. Proline 
residues are boxed and residues corresponding to predicted TMDs are underlined. 
Membrane topologies of both E and Lys PhiCb5 are shown (bottom). The N- and C-termini 
of the proteins are indicated by N and C respectively. Proline, basic, and acidic residues 
are shown as P, +, and – respectively.  
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Lysis genes from viral dark matter 
Recently, two separate groups have identified a total of 186 novel ssRNA 
genomes (55, 142). Of the 122 novel genomes identified by Krishnamurthy et al only 20 
genomes were either complete or nearly complete. The rest were partial genomes 
containing either mat or rep genes. Among 186 total genomes, only one genome 
(AVE017) had an annotated lysis gene, which was identified based on weak (<20%) aa 
similarity with the MS2 L primary structure. Thus, the genomic sequences of these new 
phages could be considered as “viral dark matter”, which serves as a great source for 
mining new lysis gene candidates and novel mechanisms of lysis. However, the lysis 
genes of ssRNA phages pose a different set of challenges for existing bioinformatic 
tools. For example, lysis genes are often small and are embedded within other genes, 
both features that confound most gene-calling tools. Additionally, due to the high error-
prone nature of Rep, the lysis proteins generally lack any significant sequence similarity 
and thus are often missed in homology based searches. To overcome these difficulties, a 
set of criteria should be defined and then algorithms designed to identify the likely lysis 
gene candidates. Since many of the known SGL proteins have a single TMD, three 
simple criteria can be established to identify lysis gene candidates with a TMD:  
1. An ORF with a Shine-Dalgarno sequence and any of the four start codons (ATG, 
GTG, TTG, and CTG). 
2. The ORF should be at least 20 codons (as a helix requires a minimum of 16 
hydrophobic aa to span the lipid bilayer). 
3. The ORF should have at least one predicted TMD. 
Additionally, another set of criteria could be set to identify candidates that have the 
characteristic features of L-like proteins: 
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1. An ORF (>20 codons) with a Shine-Dalgarno sequence upstream of any of the 4 
start codons (ATG, GTG, TTG, and CTG). 
2. A minimum of two positive charged residues at the N-terminus (K or R) 
3. A stretch of at minimum 10 mainly hydrophobic amino acids (AGVLIPF).  
4. The presence of the LS motif at the C-terminus of hydrophobic stretch. 
Although the host organism for these new ssRNA phages is not known, the 
candidates identified through the above criteria could be tested for lytic activity in E. 
coli, as the PG biosynthesis enzymes are highly conserved. The gene candidates could be 
codon-optimized for expression in E. coli, chemically synthesized, cloned in E. coli 
expression plasmids, and screened for lytic activity.  
New frontiers in ssRNA phage biology 
Isolation of new ssRNA phages 
 It is clear from recent RNA virome studies that the diversity of ssRNA phages 
has been vastly underappreciated. The diversity of lysis mechanisms among the known 
ssRNA phages and the discovery of new genes of unknown function warrant a concerted 
effort by phage biologists to isolate new ssRNA phages. Since the available ssRNA 
phage genomes are over-represented by F-specific phages, isolation of new ssRNA 
phages should focus on phages that are specific for retractable pili other than F-like pili. 
In addition to differential plating on pili (+) and pili (-) strains and RNase sensitivity 
assays, steps that aid in selectively enriching ssRNA phages should be included in phage 
isolation protocols. For example, adding a size selection step after initial phage 
enrichment stage eliminates vast number of large dsDNA phages and thus reduce the 
number phages that have to be differentially plated.  
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Revisiting the scanning model for translation of embedded genes 
It is believed that translation of the lysis gene of MS2 is dependent on translation 
reinitiation by ribosomes that reach the coat stop codon (180, 181). It is thought that the 
ribosomes that finished translation of coat randomly drift a short distance and scan for 
nearby start codons without ever leaving the mRNA. It is estimated that about 5% of the 
ribosomes that terminate at the coat stop codon backtrack to the L start codon and initiate 
translation of L. Though it is an attractive model for translation of an embedded gene, it 
does raise some interesting questions. How does the backtracking happen? Why do 
ribosomes do not dissociate? What conformational changes in ribosomes are required to 
backtrack and reinitiate? Some of these questions could be answered by cryo-electron 
microscopy and asymmetric reconstruction of translating ribosomes.  
De novo evolution of a gene 
Ever since the publication of The Origin of Species by Charles Darwin in 1859, 
different aspects of evolutionary theory have been thoroughly investigated. The advent 
of molecular biology techniques, advances in sequencing technology, and computational 
capabilities have accelerated our understanding of the molecular underpinnings of 
evolution. However, de novo evolution of a new gene with a novel function within a 
limited genomic space has not been investigated. Because of their limited genomic 
space, short life cycle, high mutation rates, and a relatively high progeny per infection 
cycle, ssRNA phages are ideal candidates to study de novo evolution of genes. Lysis 
genes in these phages are usually found embedded in other genes and take up minimal 
coding space, which indicates that they evolved recently, probably after speciation to a 
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new retractable pilus. The most common lysis proteins of Leviviridae are small 
membrane proteins that target membrane proteins of PG biosynthesis. This simplifies the 
problem of protein evolution from a three-dimensional problem to a two-dimensional 
problem. One could hypothesize that the first event is the evolution of a stretch of 
hydrophobic residues that can form a TMD and the subsequent events are aimed at 
refining target recognition and timing of lysis. Thus, lysis genes make them an ideal 
candidate to study de novo evolution. This simple ssRNA phage system could be 
engineered to go a step back in the evolutionary pathway by abolishing the lysis gene 
and then evolving the phages that restore the lysis function. Deep sequencing the 
evolving ssRNA populations would provide insights into the genetic variations that lead 
to the origin of a new gene.  
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